BCB Bancorp (BCBP) 10-Q 3 Nov 22 2022 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2022	Nov. 01, 2022
Document And Entity Information [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2022
Document Transition Report	false
Entity File Number	0-50275
Entity Registrant Name	BCB Bancorp, Inc.
Entity Incorporation, State or Country Code	NJ
Entity Tax Identification Number	26-0065262
Entity Address, Address Line One	104-110 Avenue C
Entity Address, City or Town	Bayonne
Entity Address, State or Province	NJ
Entity Address, Postal Zip Code	07002
City Area Code	201
Local Phone Number	823-0700
Title of 12(b) Security	Common Stock, no par value
Security Exchange Name	NASDAQ
Trading Symbol	BCBP
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		16,891,520
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q3
Entity Central Index Key	0001228454
Amendment Flag	false

Consolidated Statements of Fina

Consolidated Statements of Financial Condition - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
ASSETS
Cash and amounts due from depository institutions	$ 11,192	$ 9,606
Interest-earning deposits	209,832	402,023
Total cash and cash equivalents	221,024	411,629
Interest-earning time deposits	735	735
Debt securities available for sale	92,751	85,186
Equity investments	18,408	25,187
Loans held for sale		952
Loans receivable, net of allowance for loan losses of $33,195 and $37,119 respectively	2,787,015	2,304,942
Federal Home Loan Bank of New York stock, at cost	12,388	6,084
Premises and equipment, net	10,723	12,237
Accrued interest receivable	11,093	9,183
Other real estate owned	75	75
Deferred income taxes	15,863	12,959
Goodwill and other intangibles	5,394	5,431
Operating lease right-of-use assets	11,785	12,457
Bank-owned life insurance ("BOLI")	71,072	72,485
Other assets	7,286	7,986
Total Assets	3,265,612	2,967,528
LIABILITIES
Non-interest-bearing deposits	610,425	588,207
Interest bearing deposits	2,102,521	1,973,195
Total deposits	2,712,946	2,561,402
FHLB advances	212,123	71,711
Subordinated debentures	37,450	37,275
Operating lease liability	12,102	12,752
Other liabilities	8,309	10,364
Total Liabilities	2,982,930	2,693,504
STOCKHOLDERS' EQUITY
Preferred stock: $0.01 par value, 10,000,000 shares authorized; issued and outstanding 2,123 shares of Series H 3.5% and Series I 3.0%, (liquidation value $10,000 per share) noncumulative perpetual preferred stock at September 30, 2022 and 2,916 shares of Series D 4.5%, Series G 6%, Series H 3.5% and Series I 3% (liquidation value $10,000 per share) noncumulative perpetual preferred stock at December 31, 2021
Additional paid-in capital preferred stock	21,003	28,923
Common stock: no par value; 40,000,000 shares authorized; issued 19,858,738 and 19,708,375 at September 30, 2022 and December 31, 2021, respectively, outstanding 16,973,870 and 16,940,133, at September 30, 2022 and December 31, 2021, respectively
Additional paid-in capital common stock	195,057	193,927
Retained earnings	105,894	81,171
Accumulated other comprehensive loss	(6,149)	1,128
Treasury stock, at cost, 2,884,868 and 2,768,242 shares at September 30, 2022 and December 31, 2021, respectively	(33,123)	(31,125)
Total Stockholders' Equity	282,682	274,024
Total Liabilities and Stockholders' Equity	$ 3,265,612	$ 2,967,528

Consolidated Statements of Fi_2

Consolidated Statements of Financial Condition (Parenthetical) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended	12 Months Ended
	Sep. 30, 2022	Sep. 30, 2022	Dec. 31, 2021
Loans receivable, allowance for loan losses	$ 33,195	$ 33,195	$ 37,119
Preferred stock, par value per share	$ 0.01	$ 0.01	$ 0.01
Preferred stock, shares authorized	10,000,000	10,000,000	10,000,000
Preferred stock, shares issued	2,123	2,123	2,916
Preferred stock, shares outstanding	2,123	2,123	2,916
Common stock, no par value	$ 0	$ 0	$ 0
Common stock, shares authorized	40,000,000	40,000,000	40,000,000
Common stock, shares issued	19,858,738	19,858,738	19,708,375
Common stock, shares outstanding	16,973,870	16,973,870	16,940,133
Treasury stock, shares	2,884,868	2,884,868	2,768,242
Series D Preferred Stock [Member]
Preferred stock, dividend rate		4.50%	4.50%
Preferred stock, liquidation preference per share			$ 10,000
Series G Preferred Stock [Member]
Preferred stock, dividend rate		6%	6%
Preferred stock, liquidation preference per share			$ 10,000
Series H Preferred Stock [Member]
Preferred stock, dividend rate	3.50%	3.50%	3.50%
Preferred stock, liquidation preference per share	$ 10,000	$ 10,000	$ 10,000
Series I Preferred Stock [Member]
Preferred stock, dividend rate	3%	3%	3%
Preferred stock, liquidation preference per share	$ 10,000	$ 10,000	$ 10,000

Consolidated Statements of Inco

Consolidated Statements of Income - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Interest and dividend income:
Loans, including fees	$ 32,302	$ 26,922	$ 87,404	$ 80,673
Mortgage-backed securities	173	159	379	532
Other investment securities	1,103	814	2,990	2,345
FHLB stock and other interest earning assets	822	249	1,812	673
Total interest income	34,400	28,144	92,585	84,223
Deposits:
Demand	1,169	1,059	2,873	3,407
Savings and club	113	131	331	376
Certificates of deposit	1,087	1,344	2,916	4,975
Total deposits	2,369	2,534	6,120	8,758
Borrowings	1,080	997	2,701	3,226
Total interest expense	3,449	3,531	8,821	11,984
Net interest income	30,951	24,613	83,764	72,239
(Credit) provision for loan losses		680	(2,575)	4,840
Net interest income after (credit) provision for loan losses	30,951	23,933	86,339	67,399
Non-interest income:
Fees and service charges	1,251	713	3,678	2,853
BOLI income	646	765	2,087	2,195
Gain on sales of loans	18	83	126	575
Loss on bulk sale of impaired loans held in portfolio				(64)
Gain on sales of other real estate owned		11		11
Gain on sale of premises				371
Realized and unrealized (losses) on equity investments	(559)	(307)	(5,546)	(4)
Other	90	52	188	150
Total non-interest income	1,446	1,317	533	6,087
Non-interest expense:
Salaries and employee benefits	6,944	6,511	20,395	19,568
Occupancy and equipment	2,608	2,983	7,976	8,604
Data processing and communications	1,520	1,511	4,454	4,493
Professional fees	614	543	1,597	1,446
Director fees	375	233	992	790
Regulatory assessments	264	303	812	993
Advertising and promotional	286	200	681	392
Other real estate owned, net	1	(11)	6	12
Loss from extinguishment of debt		337		1,071
Other	841	918	2,555	2,899
Total non-interest expense	13,453	13,528	39,468	40,268
Income before income tax provision	18,944	11,722	47,404	33,218
Income tax provision	5,552	3,400	13,897	9,729
Net Income	13,392	8,322	33,507	23,489
Preferred stock dividends	174	286	624	852
Net Income available to common stockholders	$ 13,218	$ 8,036	$ 32,883	$ 22,637
Net Income per common share-basic and diluted
Basic	$ 0.78	$ 0.47	$ 1.94	$ 1.33
Diluted	$ 0.76	$ 0.47	$ 1.89	$ 1.31
Weighted average number of common shares outstanding
Basic	16,982	17,019	16,986	17,085
Diluted	17,356	17,222	17,369	17,242

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Consolidated Statements of Comprehensive Income [Abstract]
Net Income	$ 13,392	$ 8,322	$ 33,507	$ 23,489
Unrealized (losses) gains on available-for-sale debt securities:
Unrealized holding (losses) gains arising during the period	(4,191)	(161)	(9,675)	(12)
Tax Effect	1,039	40	2,398	3
Other comprehensive loss	(3,152)	(121)	(7,277)	(9)
Comprehensive income	$ 10,240	$ 8,201	$ 26,230	$ 23,480

Consolidated Statement of Chang

Consolidated Statement of Changes in Stockholders' Equity - USD ($) $ in Thousands	Preferred Stock [Member]	Common Stock [Member]	Additional Paid-In Capital [Member]	Retained Earnings [Member]	Treasury Stock [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Total
Beginning balance at Dec. 31, 2020			$ 217,999	$ 58,335	$ (26,918)	$ (205)	$ 249,211
Net income				23,489			23,489
Other comprehensive income						(9)	(9)
Stock-based compensation expense			337				337
Exercise of stock options			281				281
Treasury stock purchases					(2,511)		(2,511)
Dividends payable on Series D 4.5%, Series G 6%, Series H 3.5%, and Series I 3.0% noncumulative perpetual preferred stock				(852)			(852)
Cash dividends on common stock (per share declared)				(7,241)			(7,241)
Dividend reinvestment plan			343	(343)
Stock purchase plan			376				376
Ending balance at Sep. 30, 2021			219,336	73,388	(29,429)	(214)	263,081
Beginning balance at Jun. 30, 2021			218,691	68,123	(28,197)	(93)	258,524
Net income				8,322			8,322
Other comprehensive income						(121)	(121)
Stock-based compensation expense			86				86
Exercise of stock options			281				281
Treasury stock purchases					(1,232)		(1,232)
Dividends payable on Series D 4.5%, Series G 6%, Series H 3.5%, and Series I 3.0% noncumulative perpetual preferred stock				(286)			(286)
Cash dividends on common stock (per share declared)				(2,647)			(2,647)
Dividend reinvestment plan			124	(124)
Stock purchase plan			154				154
Ending balance at Sep. 30, 2021			219,336	73,388	(29,429)	(214)	263,081
Beginning balance at Dec. 31, 2021			222,850	81,171	(31,125)	1,128	274,024
Net income				33,507			33,507
Other comprehensive income						(7,277)	(7,277)
Stock-based compensation expense			458				458
Exercise of stock options			3				3
Treasury stock purchases					(1,998)		(1,998)
Dividends payable on Series D 4.5%, Series G 6%, Series H 3.5%, and Series I 3.0% noncumulative perpetual preferred stock				(624)			(624)
Redemption of Series D, G and I Preferred Stock			(14,730)				(14,730)
Issuance of Series I Preferred Stock			6,809				6,809
Cash dividends on common stock (per share declared)				(7,809)			(7,809)
Dividend reinvestment plan			351	(351)
Stock purchase plan			319				319
Ending balance at Sep. 30, 2022			216,060	105,894	(33,123)	(6,149)	282,682
Beginning balance at Jun. 30, 2022			211,130	95,393	(31,889)	(2,997)	271,637
Net income				13,392			13,392
Other comprehensive income						(3,152)	(3,152)
Stock-based compensation expense			267				267
Exercise of stock options			3				3
Treasury stock purchases					(1,234)		(1,234)
Dividends payable on Series D 4.5%, Series G 6%, Series H 3.5%, and Series I 3.0% noncumulative perpetual preferred stock				(174)			(174)
Issuance of Series I Preferred Stock			4,439				4,439
Cash dividends on common stock (per share declared)				(2,596)			(2,596)
Dividend reinvestment plan			121	(121)
Stock purchase plan			100				100
Ending balance at Sep. 30, 2022			$ 216,060	$ 105,894	$ (33,123)	$ (6,149)	$ 282,682

Consolidated Statement of Cha_2

Consolidated Statement of Changes in Stockholders' Equity (Parenthetical) - $ / shares	3 Months Ended				9 Months Ended		12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Exercise of stock options (shares)	111,750	31,000			111,950	31,000
Treasury stock purchases (shares)	116,626	91,491			71,513	189,366
Cash dividends on common stock (per share)	$ 0.16	$ 0.16	$ 0.14	$ 0.14	$ 0.48
Series D Preferred Stock [Member]
Preferred stock, dividend rate		4.50%			4.50%	4.50%	4.50%
Series G Preferred Stock [Member]
Preferred stock, dividend rate		6%			6%	6%	6%
Series H Preferred Stock [Member]
Preferred stock, dividend rate	3.50%	3.50%			3.50%	3.50%	3.50%
Series I Preferred Stock [Member]
Preferred stock, dividend rate	3%				3%		3%

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash Flows from Operating Activities:
Net Income	$ 33,507	$ 23,489
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation of premises and equipment	1,735	2,156
Amortization and accretion, net	(1,005)	(406)
(Credit) provision for loan losses	(2,575)	4,840
Deferred income tax expense (benefit)	(505)	(938)
Loans originated for sale	(5,733)	(21,927)
Proceeds from sales of loans	6,811	25,119
Gain on sales of loans originated for sale	(126)	(575)
Gain on sale of premises		(371)
Realized and unrealized losses on equity investments	5,546	4
Gain on sales of other real estate owned		(11)
Loss on bulk sale of impaired loans held in portfolio		64
Stock-based compensation expense	458	337
BOLI Income	(2,087)	(2,195)
(Increase) decrease in interest receivable	(1,910)	2,536
(Increase) decrease in other assets	700	1,313
Decrease in accrued interest payable	(214)	(803)
(Decrease) increase in other liabilities	(1,841)	454
Net Cash Provided by Operating Activities	32,761	33,086
Cash flows from investing activities:
Proceeds from repayments, calls, and maturities on securities available for sale	9,310	29,245
Purchases of securities	(26,968)	(18,345)
Proceeds from bulk sale of impaired loans		3,442
Proceeds from sales of securities	1,232
Net increase in loans receivable	(477,429)	(1,671)
Purchases of BOLI		(8,500)
Proceeds from BOLI	3,500
Proceeds from sales of other real estate owned		425
Additions to premises and equipment	(221)	(254)
Proceeds from the sale of fixed assets and premises		742
Redemption of Federal Home Loan Bank of New York stock	(6,304)	3,131
Net Cash Used In Investing Activities	(496,880)	8,215
Cash flows from financing activities:
Net increase in deposits	151,544	223,355
Proceeds from Federal Home Loan Bank of New York Advances	140,000	10,000
Repayments of Federal Home Loan Bank of New York Advances		(83,000)
Purchases of treasury stock	(1,998)	(2,511)
Cash dividends paid on common stock	(7,809)	(7,241)
Cash dividends paid on preferred stock	(624)	(852)
Net proceeds from issuance of common stock	319	376
Net proceeds from issuance of preferred stock	6,809
Net payment for redemption of preferred stock	(14,730)
Proceeds from exercise of stock options	3	281
Net Cash Provided by Financing Activities	273,514	140,408
Net Increase (Decrease) in Cash and Cash Equivalents	(190,605)	181,709
Cash and Cash Equivalents - Beginning	411,629	261,229
Cash and Cash Equivalents - Ending	221,024	442,938
Supplementary Cash Flow Information:
Cash paid during the period for income taxes	16,532	10,150
Cash paid during the period for interest	$ 9,036	$ 12,787

Basis of Presentation

Basis of Presentation	9 Months Ended
	Sep. 30, 2022
Basis of Presentation [Abstract]
Basis of Presentation	Note 1 – Basis of Presentation The accompanying unaudited consolidated financial statements include the accounts of BCB Bancorp, Inc. (the “Company”) and the Company’s wholly owned subsidiaries, BCB Community Bank (the “Bank”), BCB Holding Company Investment Corporation, Special Asset REO I, LLC., and Special Asset REO II, LLC. The Company’s business is conducted principally through the Bank. All significant intercompany accounts and transactions have been eliminated in consolidation. The accompanying unaudited consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q and Regulation S-X and, therefore, do not necessarily include all information that would be included in audited consolidated financial statements. The information furnished reflects all adjustments that are, in the opinion of management, necessary for a fair presentation of consolidated financial condition and results of operations. All such adjustments are of a normal recurring nature. These results are not necessarily indicative of the results to be expected for the fiscal year ending December 31 , or any other future period. The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the consolidated statement of financial condition and revenues and expenses for the periods then ended. Actual results could differ significantly from those estimates. These unaudited consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and related notes for the year ended December 31, 2021, which are included in the Company’s Annual Report on Form 10-K as filed with the Securities and Exchange Commission. In preparing these consolidated financial statements, the Company evaluated the events and transactions that occurred between December 31, 2021 and the date these consolidated financial statements were issued. Risks and Uncertainties - We are subject to risks and uncertainties as a result of the COVID-19 pandemic. The full fallout from the pandemic and its long-term impact on economies, markets, industries and financial institutions is not known at this time, and it may take years to fully determine COVID-19’s economic impact. The occurrence of events which adversely affect the global, national and regional economies may have a negative impact on our business. Like other financial institutions, our business relies upon the ability and willingness of our customers to transact business with us, including banking, borrowing and other financial transactions. A strong and stable economy at each of the local, federal and global levels is often a critical component of consumer confidence and typically correlates positively with our customers’ ability and willingness to transact certain types of business with us. Local and global events outside of our control which disrupt the New Jersey, New York, United States and/or global economy may therefore negatively impact our business and financial condition. A public health crisis such as the COVID-19 pandemic is no exception, and its adverse health and economic effects may adversely impact our business and financial condition. As of the date of issuance of the condensed consolidated financial statements, the extent to which the COVID-19 pandemic may impact the Company’s financial condition, liquidity, or results of operations is uncertain.

Recent Accounting Pronouncement

Recent Accounting Pronouncements	9 Months Ended
	Sep. 30, 2022
Recent Accounting Pronouncements [Abstract]
Recent Accounting Pronouncements	Note 2 - Recent Accounting Pronouncements In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016-13, Financial Instruments - Credit Losses ASU 2016-13, and related guidance, requires entities to report “expected” credit losses on financial instruments and other commitments to extend credit rather than the current “incurred loss” model. These expected credit losses for financial assets held at the reporting date are to be based on historical experience, current conditions, and reasonable and supportable forecasts. This ASU will also require enhanced disclosures to help investors and other financial statement users better understand significant estimates and judgments used in estimating credit losses, as well as the credit quality and underwriting standards of an entity’s portfolio. These disclosures include qualitative and quantitative requirements that provide additional information about the amounts recorded in the consolidated financial statements. The amendments are effective for the Company in 2023. The Company has begun evaluating the impact the adoption of ASU 2016-13 will have on its consolidated financial statements and results of operations. The effect of this change cannot be ascertained at this point, and will depend upon factors including asset components, asset quality and market conditions at the adoption date. The Company has created a Current Expected Credit Loss (“CECL”) task group comprised of members of its finance, credit administration, lending, internal audit, loan operations, compliance, and information systems units. The CECL task group has become familiar with the provisions of ASU 2016-13 and is in the process of implementing the new guidance, which includes, but is not limited to: (1) identifying segments and sub-segments within the loan portfolio that have similar risk characteristics; (2) determining the appropriate methodology for each segment; (3) implementing changes that are necessary to its core operating system and interfaces to be able to capture appropriate data requirements; and (4) evaluating qualitative and economic factors to develop appropriate forecasts for integration into the model. The Company is currently evaluating the effect this guidance may have on its operating results and/or financial position, including assessing any potential impact on its capital.

Reclassification

Reclassification	9 Months Ended
	Sep. 30, 2022
Reclassification [Abstract]
Reclassification	Note 3 – Reclassification Certain amounts as of December 31, 2021 and for the nine month period ended September 30, 2021 have been reclassified to conform to the current period’s presentation. These changes had no effect on the Company’s results of operations or financial position.

Equity Incentive Plans

Equity Incentive Plans	9 Months Ended
	Sep. 30, 2022
Equity Incentive Plans [Abstract]
Equity Incentive Plans	Note 4 – Equity Incentive Plans Equity Incentive Plans The Company, under the plan approved by its shareholders on April 28, 2011 (“2011 Stock Plan”), authorized the issuance of up to 900,000 shares of common stock of the Company pursuant to grants of stock options. Employees and directors of the Company and the Bank were eligible to participate in the 2011 Stock Plan. All stock options were granted in the form of either "incentive" stock options or "non-qualified" stock options. Incentive stock options have certain tax advantages that must comply with the requirements of Section 422 of the Internal Revenue Code. Only employees were permitted to receive incentive stock options. No awards were permitted to be granted under this Plan after April 26, 2021 pursuant to the terms of the 2011 Equity Incentive Plan (defined below). The Company, under the plan approved by its shareholders on April 26, 2018 (“2018 Equity Incentive Plan”), authorized the issuance of up to 1,000,000 shares of common stock of the Company pursuant to grants of stock options, restricted stock awards, restricted stock units, and performance awards. Employees and directors of the Company and the Bank are eligible to participate in the 2018 Equity Incentive Plan. All stock options will be granted in the form of either "incentive" stock options or "non-qualified" stock options. Incentive stock options have certain tax advantages that must comply with the requirements of Section 422 of the Internal Revenue Code. Only employees are permitted to receive incentive stock options. Under the 2018 Equity Incentive Plan, on February 10, 2021, grants of 66,000 options, in aggregate, were declared for members of the Board of Directors of the Bank and the Company which vest over a 5 -year period, commencing on the first anniversary of the grant date. The exercise price was recorded as of close of business on February 10, 2021. On February 10, 2021, awards of 26,400 shares of restricted stock, in aggregate, were declared for members of the Board of Directors of the Bank and the Company, which vest over a 4 -year period, commencing on the anniversary of the award date. On February 19, 2021, an award of 300 shares of restricted stock was declared for an officer of the Bank and the Company, which vests over a 2 -year period, commencing on the anniversary of the award date. Further, on April 26, 2021, grants of 6,800 options, in aggregate, were declared for certain officers of the Bank and the Company, which vest over a 5 -year period commencing on the first anniversary of the grant date. The exercise price was recorded as of close of business on April 26, 2021. On January 12, 2022, awards of 33,000 shares of restricted stock, in aggregate, were declared for members of the Board of Directors of the Bank and the Company, which vest over a 4 -year period, commencing on the anniversary of the award date. Note 4 – Equity Incentive Plans (Continued) The following table presents a summary of the status of the Company’s restricted shares as of September 30, 2022 and 2021. Number of Shares Awarded Weighted Average Grant Date Fair Value Non-vested at January 1, 2022 26,700 $ 12.89 Granted 69,000 17.05 Vested ( 9,150 ) 13.91 Forfeited - - Non-vested at September 30, 2022 86,550 $ 16.19 Restricted stock expense for the nine months ended September 30, 2022 and September 30, 2021 was $ 278,000 and $ 162,000 , respectively. Expected future expenses relating to the non-vested restricted shares outstanding as of September 30, 2022 was approximately $ 1.1 million over a weighted average period of 1.65 years . The following table presents a summary of the status of the Company’s outstanding stock option awards as of September 30, 2022. Number of Option Shares Range of Exercise Prices Weighted Average Exercise Price Outstanding at January 1, 2022 1,194,425 $ 9.02 - 13.68 $ 11.64 Options granted - - - Options exercised ( 111,950 ) 9.02 - 13.68 11.52 Options forfeited - - - Options expired - - - Outstanding at September 30, 2022 1,082,475 $ 9.02 - 13.68 $ 11.65 As of September 30, 2022, stock options which were granted and were exercisable totaled 844,035 . It is Company policy to issue new shares upon share option exercise. Compensation expense for the nine months ended September 30, 2022 and September 30, 2021 was $ 180,000 and $ 175,000 , respectively. Expected future compensation expense relating to the 238,440 shares of unvested options outstanding as of September 30, 2022 was $ 418,000 over a weighted average period of 3.91 years.

Net Income per Common Share

Net Income per Common Share	9 Months Ended
	Sep. 30, 2022
Net Income per Common Share [Abstract]
Net Income per Common Share	Note 5 – Net Income per Common Share Basic net income per common share is computed by dividing net income less dividends on preferred stock by the weighted average number of shares of common stock outstanding. The diluted net income per common share is computed by adjusting the weighted average number of shares of common stock outstanding to include the effects of outstanding stock options, if dilutive, using the treasury stock method. Dilution is not applicable in periods of net loss. For the three months ended September 30, 2022 and 2021, the difference in the weighted average number of basic and diluted common shares was due solely to the effects of outstanding stock options. No adjustments to net income were necessary in calculating basic and diluted net income per share. For the three months ended September 30, 2022 and 2021, the weighted average number of outstanding options considered to be anti-dilutive were 0 and 0 , respectively. For the nine months ended September 30, 2022 and 2021, the weighted average number of outstanding options considered to be anti-dilutive were 0 and 7,015 , respectively. The following is a reconciliation of the numerators and denominators of the basic and diluted earnings per share computations: For the Three Months Ended September 30, 2022 2021 Income Shares Per Share Income Shares Per Share (Numerator) (Denominator) Amount (Numerator) (Denominator) Amount (In Thousands, except per share data) Basic earnings per share: Income available to common stockholders $ 13,218 16,982 $ 0.78 $ 8,036 17,019 $ 0.47 Effect of dilutive securities: - - - - Stock options - 374 - 203 Diluted earnings per share: Income available to common stockholders $ 13,218 17,356 $ 0.76 $ 8,036 17,222 $ 0.47 For the Nine Months Ended September 30, 2022 2021 Income Shares Per Share Income Shares Per Share (Numerator) (Denominator) Amount (Numerator) (Denominator) Amount (In Thousands, except per share data) Basic earnings per share: Income available to common stockholders $ 32,883 16,986 $ 1.94 $ 22,637 17,085 $ 1.33 Effect of dilutive securities: Stock options - 383 - 157 Diluted earnings per share: Income available to common stockholders $ 32,883 17,369 $ 1.89 $ 22,637 17,242 $ 1.31

Securities

Securities	9 Months Ended
	Sep. 30, 2022
Securities [Abstract]
Securities	Note 6 - Securities Equity Securities Equity securities are defined to include (a) preferred, common and other ownership interests in entities including partnerships, joint ventures and limited liability companies and (b) rights to acquire or dispose of ownership interest in entities at fixed or determinable prices. The following is a summary of unrealized and realized gains and losses recognized in net income on equity securities during the three and nine months ended September 30, 2022 and 2021: For the three months ended September 30, For the nine months ended September 30, (In Thousands) 2022 2021 2022 2021 Net (losses) gains recognized during the period on equity securities held at the reporting date $ ( 559 ) $ ( 307 ) $ ( 5,487 ) $ ( 4 ) Net losses recognized during the period on equity securities sold during the period - - ( 59 ) - Realized and unrealized losses on equity investments during the reporting period $ ( 559 ) $ ( 307 ) $ ( 5,546 ) $ ( 4 ) Note 6 - Securities (continued) Debt Securities Available for Sale The following tables present by maturity the amortized cost, gross unrealized gains and losses on, and fair value of, securities available for sale as of September 30, 2022 and December 31, 2021: September 30, 2022 Gross Gross Amortized Unrealized Unrealized Cost Gains Losses Fair Value (In Thousands) Residential Mortgage-backed securities: Less than one year $ - $ - $ - $ - More than one to five years - - - - More than five to ten years 5,754 - 401 5,353 More than ten years 23,708 - 3,620 20,088 Sub-total: 29,462 - 4,021 25,441 Corporate Debt securities: More than five to ten years 66,499 - 3,199 63,300 Sub-total: 66,499 - 3,199 63,300 Municipal obligations: More than ten years 4,025 - 15 4,010 Sub-total: 4,025 - 15 4,010 Total securities $ 99,986 $ - $ 7,235 $ 92,751 December 31, 2021 Gross Gross Amortized Unrealized Unrealized Cost Gains Losses Fair Value (In Thousands) Residential Mortgage-backed securities: Due within one year $ 2,952 $ - $ 114 $ 2,838 More than one to five years 53 - - 53 More than five to ten years 6,317 165 27 6,455 More than ten years 21,555 298 287 21,566 Sub-total: 30,877 463 428 30,912 Corporate Debt securities: More than five to ten years 47,765 2,465 159 50,071 Sub-total: 47,765 2,465 159 50,071 Municipal obligations: Due after ten years 4,104 99 - 4,203 Sub-total: 4,104 99 - 4,203 Total Debt Securities Available $ 82,746 $ 3,027 $ 587 $ 85,186 Note 6 - Securities (continued) The unrealized losses, categorized by the length of time of continuous loss position, and fair value of related securities available for sale were as follows: 12 Months or Less More than 12 Months Total Fair Unrealized Fair Unrealized Fair Unrealized Value Losses Value Losses Value Losses (In Thousands) September 30, 2022 Residential mortgage-backed securities $ 19,430 $ 2,441 $ 6,012 $ 1,580 $ 25,442 $ 4,021 Corporate Debt securities 56,521 3,079 5,978 120 62,499 3,199 Municipal bond 4,010 15 4,010 15 $ 79,961 $ 5,535 $ 11,990 $ 1,700 $ 91,951 $ 7,235 December 31, 2021 Residential mortgage-backed securities $ 7,801 $ 159 $ 4,681 $ 269 $ 12,482 $ 428 Corporate Debt Securities 12,324 159 - - 12,324 159 $ 20,125 $ 318 $ 4,681 $ 269 $ 24,806 $ 587 Management evaluates securities for other-than-temporary impairment (“OTTI”) at least on a quarterly basis, and more frequently when economic or market conditions warrant such evaluation. Consideration is given to (1) the length of time and the extent to which the fair value has been less than cost, (2) the financial condition and near-term prospects of the issuer, and (3) whether the Company intends to sell the security or more likely than not will be required to sell the security before its anticipated recovery. At September 30, 2022 and December 31, 2021, management performed an assessment for possible OTTI of the Company’s residential mortgage-backed securities and corporate debt on an issue-by-issue basis, relying on information obtained from various sources, including publicly available financial data, ratings by external agencies, brokers and other sources. The extent of individual analysis applied to each security depends on the size of the Company’s investment, as well as management’s perception of the credit risk associated with each security. Based on the results of the assessment, management believes impairment of these securities, at September 30, 2022 and December 31, 2021, to be temporary.

Loans Receivable and Allowance

Loans Receivable and Allowance for Loan Losses	9 Months Ended
	Sep. 30, 2022
Loans Receivable and Allowance for Loan Losses [Abstract]
Loans Receivable and Allowance for Loan Losses	Note 7 - Loans Receivable and Allowance for Loan Losses The following tables present the recorded investment in loans receivable as of September 30, 2022 and December 31, 2021 by segment and class: September 30, 2022 December 31, 2021 (In Thousands) Residential one-to-four family $ 242,238 $ 224,534 Commercial and multi-family 2,164,320 1,720,174 Construction 153,103 153,904 Commercial business (1) 205,661 191,139 Home equity (2) 56,064 50,469 Consumer 2,545 3,717 2,823,931 2,343,937 Less: Deferred loan fees, net ( 3,721 ) ( 1,876 ) Allowance for loan losses ( 33,195 ) ( 37,119 ) Total Loans, net $ 2,787,015 $ 2,304,942 (1) Includes business lines of credit. (2) Includes home equity lines of credit. Note 7 – Loans Receivable and Allowance for Loan Losses (Continued) Allowance for Loan Losses The allowance for loan loss is evaluated regularly by management and reflects consideration of all significant factors that affect the collectability of the loan portfolio. The Company’s methodology for assessing the adequacy of the allowance for loan losses consists of several key elements. These elements include a general allocated reserve for performing loans, a specific reserve for impaired loans and an unallocated portion. The Company consistently applies the following comprehensive methodology. During the quarterly review of the allowance for loan losses, the Company considers a variety of qualitative factors that include:  Lending policies and procedures;  Personnel responsible for the particular portfolio - relative to experience and ability of staff;  Trend for past due, criticized and classified loans;  Relevant economic factors;  Quality of the loan review system;  Value of collateral for collateral dependent loans;  The effect of any concentrations of credit and the changes in the level of such concentrations; and  Other external factors. The methodology includes the segregation of the loan portfolio into two divisions: performing loans and loans determined to be impaired. Loans which are performing are evaluated homogeneously by loan class or loan type. The allowance for performing loans is evaluated based on historical loan loss experience with an adjustment for the qualitative factors listed above. Impaired loans can be loans which are more than 90 days delinquent, troubled debt restructurings, in the process of foreclosure, or a forced bankruptcy plan. These loans are individually evaluated for loan loss either by current appraisal, or net present value of expected cash flows. Management reviews the overall estimate for feasibility and bases the loan loss provision accordingly. During 2022 and 2021, additional stress tests were performed to model a potential collateral deficiency on those loans that are in sectors that have demonstrated a weakness in the current COVID environment. The Bank also maintains an unallocated allowance to cover uncertainties that could affect management’s estimate of probable losses. The unallocated component of the allowance reflects the margin of imprecision inherent in the underlying assumptions used in the methodologies for estimating allocated and general reserves in the portfolio. Management must make estimates using assumptions and information that is often subjective and subject to change. The loan portfolio is segmented into the following loan segments, where the risk level for each class is analyzed when determining the allowance for loan losses: Residential one-to-four family real estate loans involve certain risks such as interest rate risk and risk of non-repayment. Adjustable-rate residential real estate loans decrease the interest rate risk to the Bank that is associated with changes in interest rates but involve other risks, primarily because as interest rates rise, the payment by the borrower rises to the extent permitted by the terms of the loan, thereby increasing the potential for default. At the same time, the marketability of the underlying properties may be adversely affected by higher interest rates. Repayment risk may be affected by a number of factors including, but not necessarily limited to, job loss, divorce, illness and personal bankruptcy of the borrower. Commercial and multi-family real estate lending entails additional risks as compared with residential family property lending. Such loans typically involve large loan balances to single borrowers or groups of related borrowers. The payment experience on such loans is typically dependent on the successful operation of the real estate project. The success of such projects is sensitive to changes in supply and demand conditions in the market for commercial real estate as well as general economic conditions. Construction lending is generally considered to involve a high risk due to the concentration of principal in a limited number of loans and borrowers and the effects of the general economic conditions on developers and builders. Moreover, a construction loan can involve additional risks because of the inherent difficulty in estimating both a property’s value at completion of the project and the estimated cost (including interest) of the project. The nature of these loans is such that they are generally difficult to evaluate and monitor. In addition, speculative construction loans to a builder are not necessarily pre-sold and thus pose a greater potential risk to the Bank than construction loans to individuals on their personal residence. Commercial business lending, including lines of credit, is generally considered higher risk due to the concentration of principal in a limited number of loans and borrowers and the effects of general economic conditions on the business. Commercial business loans are primarily secured by inventories and other business assets. In many cases, any repossessed collateral for a defaulted commercial business loans will not provide an adequate source of repayment of the outstanding loan balance. Home equity lending entails certain risks such as interest rate risk and risk of non-repayment. The marketability of the underlying property may be adversely affected by higher interest rates, decreasing the collateral value securing the loan. Repayment risk can be affected by job loss, divorce, illness and personal bankruptcy of the borrower. Home equity line of credit lending entails securing an equity interest in the borrower’s home. In many cases, the Bank’s position in these loans is as a junior lien holder to another institution’s superior lien. This type of lending is often priced on an adjustable rate basis with the rate set at or above a predefined index. Adjustable-rate loans decrease the interest rate risk to the Bank that is associated with changes in interest rates but involve other risks, primarily because as interest rates rise, the payment by the borrower rises to the extent permitted by the terms of the loan, thereby increasing the potential for default. Other consumer loans generally have more credit risk because of the type and nature of the collateral and, in certain cases, the absence of collateral. Consumer loans generally have shorter terms and higher interest rates than other lending. In addition, consumer lending collections are dependent on the borrower’s continuing financial stability, and thus are more likely to be adversely affected by job loss, divorce, illness and personal bankruptcy. In many cases, any repossessed collateral for a defaulted consumer loan will not provide an adequate source of repayment of the outstanding loan. Note 7 - Loans Receivable and Allowance for Loan Losses (Continued) The following table sets forth the activity in the Company’s allowance for loan losses for the three and nine months ended September 30, 2022, and the related portion of the allowances for loan losses that is allocated to each loan class, as of September 30, 2022 (in thousands): Residential Commercial & Multi-family Construction Commercial Business (1) Home Equity (2) Consumer Unallocated Total Allowance for loan losses: Beginning Balance, July 1, 2022 $ 2,565 $ 21,157 $ 2,348 $ 7,639 $ 387 $ 17 - $ 34,113 Charge-offs: - - - ( 931 ) - - ( 931 ) Recoveries: 7 - - 2 4 - - 13 (Credit) Provisions: ( 374 ) 390 96 ( 993 ) 75 3 803 - Ending Balance, September 30, 2022 2,198 21,547 2,444 5,717 466 20 803 33,195 Ending Balance attributable to loans: Individually evaluated for impairment 204 - 519 3,509 6 - - 4,238 Collectively evaluated for impairment 1,994 21,547 1,925 2,208 460 20 803 28,957 Ending Balance, September 30, 2022 2,198 21,547 2,444 5,717 466 20 803 33,195 Loans Receivables: Individually evaluated for impairment 4,914 27,090 3,180 4,607 733 - - 40,524 Collectively evaluated for impairment 237,324 2,137,230 149,923 201,054 55,331 2,545 - 2,783,407 Total Gross Loans: $ 242,238 $ 2,164,320 $ 153,103 $ 205,661 $ 56,064 $ 2,545 $ - $ 2,823,931 (1) Includes business lines of credit. (2) Includes home equity lines of credit. Residential Commercial & Multi-family Construction Commercial Business (1) Home Equity (2) Consumer Unallocated Total Allowance for loan losses: Beginning Balance, January 1, 2022 $ 4,094 $ 22,065 $ 2,231 $ 8,000 $ 533 $ 14 $ 182 $ 37,119 Charge-offs: - - - ( 1,703 ) - - - ( 1,703 ) Recoveries: 9 - - 138 9 198 - 354 (Credit) Provisions: ( 1,905 ) ( 518 ) 213 ( 718 ) ( 76 ) ( 192 ) 621 ( 2,575 ) Ending Balance, September 30, 2022 $ 2,198 $ 21,547 $ 2,444 $ 5,717 $ 466 $ 20 $ 803 $ 33,195 _____________________________ (1) Includes business lines of credit. (2) Includes home equity lines of credit. Note 7 - Loans Receivable and Allowance for Loan Losses (Continued) The following table sets forth the activity in the Company’s allowance for loan losses for the three and nine months ended September 30, 2021, and the related portion of the allowances for loan losses that is allocated to each loan class, as of September 30, 2021 (in thousands): Residential Commercial & Multi-family Construction Commercial Business (1) Home Equity (2) Consumer Unallocated Total Allowance for loan losses: Beginning Balance, July 1, 2021 $ 2,911 $ 24,438 $ 2,341 $ 6,852 $ 294 - $ 3 $ 633 $ 37,472 Charge-offs: - - - - - - - - Recovery: - - - 1 3 - - 4 (Credit) Provisions: ( 75 ) 370 ( 307 ) 879 19 20 ( 226 ) 680 Ending Balance September 30, 2021 $ 2,836 $ 24,808 $ 2,034 $ 7,732 $ 316 $ 23 $ 407 $ 38,156 Ending Balance attributable to loans: Individually evaluated for impairment $ 276 $ 1,469 $ 150 $ 5,770 $ 16 $ - $ - $ 7,681 Collectively evaluated for impairment 2,560 23,339 1,884 1,962 300 23 407 30,475 Ending Balance September 30, 2021 $ 2,836 $ 24,808 $ 2,034 $ 7,732 $ 316 $ 23 $ 407 $ 38,156 Loans Receivables: Individually evaluated for impairment $ 5,104 $ 39,356 $ 2,787 $ 10,343 $ 1,273 $ - $ - $ 58,863 Collectively evaluated for impairment 219,226 1,700,620 146,289 151,073 50,836 2,730 - 2,270,774 Total Gross Loans: $ 224,330 $ 1,739,976 $ 149,076 $ 161,416 $ 52,109 $ 2,730 $ - $ 2,329,637 _____________________________ (1) Includes business lines of credit. (2) Includes home equity lines of credit. Residential Commercial & Multi-family Construction Commercial Business (1) Home Equity (2) Consumer Unallocated Total Allowance for loan losses: Beginning Balance, January 1, 2021 $ 3,293 $ 21,772 $ 1,977 $ 6,306 $ 286 $ - $ 5 $ 33,639 Charge-offs: ( 60 ) - - ( 103 ) - ( 198 ) - ( 361 ) Recovery: 27 - - 2 - 9 - 38 (Credit) Provisions: ( 424 ) 3,036 57 1,527 30 212 402 4,840 Ending Balance, September 30, 2021 $ 2,836 $ 24,808 $ 2,034 $ 7,732 $ 316 $ 23 $ 407 $ 38,156 _____________________________ (1) Includes business lines of credit. (2) Includes home equity lines of credit. The following table sets forth the amount recorded in loans receivable at December 31, 2021. The table also details the amount of total loans receivable that are evaluated individually, and collectively, for impairment and the related portion of the allowance for loan losses that is allocated to each loan class (in thousands): Residential Commercial & Multi-family Construction Commercial Business (1) Home Equity (2) Consumer Unallocated Total Allowance for credit losses: Ending Balance attributable to loans: Individually evaluated for impairment $ 265 $ 1,690 $ 210 $ 5,650 $ 13 $ - $ - $ 7,828 Collectively evaluated for impairment 3,829 20,375 2,021 2,350 520 14 182 29,291 Ending Balance, December 31, 2021 $ 4,094 $ 22,065 $ 2,231 $ 8,000 $ 533 $ 14 $ 182 $ 37,119 Loans Receivables: Individually evaluated for impairment $ 4,961 $ 31,745 $ 2,847 $ 8,746 $ 1,083 $ - $ - $ 49,382 Collectively evaluated for impairment 219,573 1,688,429 151,057 182,393 49,386 3,717 - 2,294,555 Total Gross Loans: $ 224,534 $ 1,720,174 $ 153,904 $ 191,139 $ 50,469 $ 3,717 $ - $ 2,343,937 (1) Includes business lines of credit. (2) Includes home equity lines of credit. Note 7 - Loans Receivable and Allowance for Loan Losses (Continued) The following table summarizes the average recorded investment and interest income recognized on impaired loans with no related allowance recorded by portfolio class for the three and nine months ended September 30, 2022 and 2021 (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2022 2022 2021 2021 2022 2022 2021 2021 Average Interest Average Interest Average Interest Average Interest Recorded Income Recorded Income Recorded Income Recorded Income Investment Recognized Investment Recognized Investment Recognized Investment Recognized Loans with no related allowance recorded: Residential one-to-four family $ 2,862 $ 36 $ 3,050 $ 37 $ 2,881 $ 109 $ 2,973 $ 108 Commercial and Multi-family 27,360 315 29,742 271 25,415 901 30,614 830 Construction - - - - - - 929 36 Commercial business (1) 828 3 2,465 65 1,149 73 3,143 104 Home equity (2) 488 7 938 12 474 17 1,048 35 Consumer - - - - - - - - Total Impaired Loans with no allowance recorded: $ 31,538 $ 361 $ 36,195 $ 385 $ 29,919 $ 1,100 $ 38,707 $ 1,113 - - Loans with an allowance recorded: Residential one-to-four family $ 1,989 24 $ 2,110 $ 66 $ 1,964 $ 61 $ 2,302 $ 165 Commercial and Multi-family - 10,942 100 1,125 266 11,204 331 Construction 3,112 - 2,787 3 3,059 22 1,858 6 Commercial business (1) 4,567 - 8,197 24 4,953 65 8,388 141 Home equity (2) 264 - 340 - 276 5 368 2 Consumer - - - - - - - - Total Impaired Loans with an allowance recorded: $ 9,932 $ 24 $ 24,376 $ 193 $ 11,377 $ 419 $ 24,120 $ 645 - - Total Impaired Loans: $ 41,470 $ 385 $ 60,571 $ 578 $ 41,296 $ 1,519 $ 62,827 $ 1,758 __________ (1) Includes business lines of credit. (2) Includes home equity lines of credit. The following table summarizes the recorded investment by portfolio class at September 30, 2022 and December 31, 2021. (in thousands): As of September 30, 2022 As of December 31, 2021 Recorded Unpaid Principal Related Recorded Unpaid Principal Related Investment Balance Allowance Investment Balance Allowance Loans with no related allowance recorded: Residential one-to-four family $ 2,845 $ 3,209 $ - $ 2,950 $ 3,300 $ - Commercial and multi-family 27,090 28,266 - 20,915 22,100 - Construction - - - - - - Commercial business (1) 947 4,910 - 2,114 6,905 - Home equity (2) 504 504 - 779 780 - Total Impaired Loans with no related allowance recorded: $ 31,386 $ 36,889 $ - $ 26,758 $ 33,085 $ - Loans with an allowance recorded: Residential one-to-four family $ 2,069 $ 2,090 $ 204 $ 2,011 $ 2,032 $ 265 Commercial and Multi-family - - - 10,830 14,494 1,690 Construction 3,180 3,180 519 2,847 2,847 210 Commercial business (1) 3,660 8,519 3,509 6,632 17,514 5,650 Home equity (2) 229 229 6 304 304 13 Total Impaired Loans with an allowance recorded: $ 9,138 $ 14,018 $ 4,238 $ 22,624 $ 37,191 $ 7,828 Total Impaired Loans: $ 40,524 $ 50,907 $ 4,238 $ 49,382 $ 70,276 $ 7,828 __________ (1) Includes business lines of credit. (2) Includes home equity lines of credit. Note 7 - Loans Receivable and Allowance for Loan Losses (Continued) A troubled debt restructured loan (“TDR”) is a loan that has been modified whereby the Company has agreed to make certain concessions to a borrower to meet the needs of both the borrower and the Company to maximize the ultimate recovery of a loan. A TDR occurs when a borrower is experiencing, or is expected to experience, financial difficulties and the loan is modified using a concession that would otherwise not be granted to the borrower. All TDRs were considered impaired and therefore were individually evaluated for impairment in the calculation of the allowance for loan losses. Prior to their classification as TDRs, certain of these loans had been collectively evaluated for impairment in the calculation of the allowance for loan losses. At September 30, 2022 At December 31, 2021 (In thousands) Recorded investment in TDRs: Accrual status $ 10,503 $ 12,402 Non-accrual status 483 3,570 Total recorded investment in TDRs $ 10,986 $ 15,972 The Company granted one TDR loan of $ 180,078 and one TDR loan of $ 168,102 for the three months ended September 30, 2022 and September 30, 2021, respectively. For the three months ended September 30, 2022 and September 30, 2021, TDRs, for which there was a payment default within twelve months of restructuring, totaled $ 0 and $ 232,072 for one loan, respectively. The following table sets forth the delinquency status of total loans receivable as of September 30, 2022: Loans Receivable 30-59 Days 60-90 Days Greater Than Total Past Total Loans >90 Days Past Due Past Due 90 Days Due Current Receivable and Accruing (In Thousands) Residential one-to-four family $ 615 $ 187 $ 230 $ 1,032 $ 241,206 $ 242,238 $ 230 Commercial and multi-family 2,245 356 757 3,358 2,160,962 2,164,320 - Construction - - 3,180 3,180 149,923 153,103 - Commercial business (1) 885 47 1,578 2,510 203,151 205,661 - Home equity (2) 199 - - 199 55,865 56,064 - Consumer - - - 2,545 2,545 - Total $ 3,944 $ 590 $ 5,745 $ 10,279 $ 2,813,652 $ 2,823,931 $ 230 _________ (1) Includes business lines of credit. (2) Includes home equity lines of credit. The following table sets forth the delinquency status of total loans receivable at December 31, 2021: Loans Receivable 30-59 Days 60-90 Days Greater Than Total Past Total Loans >90 Days Past Due Past Due 90 Days Due Current Receivable and Accruing (In Thousands) Residential one-to-four family $ 1,063 $ - $ 86 $ 1,149 $ 223,385 $ 224,534 $ - Commercial and multi-family 1,181 - 5,167 6,348 1,713,826 1,720,174 - Construction 2,899 - 2,847 5,746 148,158 153,904 - Commercial business (1) 405 166 6,775 7,346 183,793 191,139 3,124 Home equity (2) 190 - 27 217 50,252 50,469 - Consumer - - - - 3,717 3,717 - Total $ 5,738 $ 166 $ 14,902 $ 20,806 $ 2,323,131 $ 2,343,937 $ 3,124 (1) Includes business lines of credit. (2) Includes home equity lines of credit. Note 7 - Loans Receivable and Allowance for Loan Losses (Continued) The table below sets forth the amounts and types of non-accrual loans in the Bank’s loan portfolio at September 30, 2022 and December 31, 2021, respectively. Loans are placed on non-accrual status when they become more than 90 days delinquent, or when the collection of principal and/or interest become doubtful. As of September 30, 2022, and December 31, 2021, non-accrual loans differed from the amount of total loans past due greater than 90 days due to troubled debt restructuring of loans, loans 90 days past due and still accruing, or loans that were previously 90 days past due which are maintained on non-accrual status for a minimum of six months until the borrower has demonstrated its ability to satisfy the terms of the loan. There were $ 230,000 at September 30, 2022 and $ 3.8 million at December 31, 2021 in nonaccrual loans that were less than ninety days past due. Nonaccrual loans do not include loans acquired with deteriorated credit quality which were recorded at their fair value at acquisition and totaled $ 0 at September 30, 2022 and $ 670,000 at December 31, 2021. As of September 30, 2022 As of December 31, 2021 (In Thousands) (In Thousands) Non-Accruing Loans: Residential one-to-four family $ 263 $ 282 Commercial and multi-family 757 8,601 Construction 3,180 2,847 Commercial business (1) 4,305 3,132 Home equity (2) - 27 Total $ 8,505 $ 14,889 _________ (1) Includes business lines of credit. (2) Includes home equity lines of credit. Had non-accrual loans been performing in accordance with their original terms, the interest income recognized for the nine months ended September 30, 2022 and the twelve months ended December 31, 2021 would have been approximately $ 842,000 and $ 1.3 million, respectively. Note 7 - Loans Receivable and Allowance for Loan Losses (Continued) Criticized and Classified Assets Company policies provide for a classification system for problem assets. Under this classification system, problem assets are classified as “substandard,” “doubtful,” or “loss.” When the Company classifies problem assets, the Company may establish general allowances for loan losses in an amount deemed prudent by management. General allowances represent loss allowances which have been established to recognize the inherent risk associated with lending activities, but which, unlike specific allowances, have not been allocated to particular problem assets. A portion of general loss allowances established to cover possible losses related to assets classified as substandard or doubtful may be included in determining the Company’s regulatory capital. Specific valuation allowances for loan losses generally do not qualify as regulatory capital. The loans classified as substandard are secured either by residential real estate, commercial real estate or heavy equipment. The loans that have been classified substandard were classified as such primarily due to payment status, because updated financial information has not been timely provided, or the collateral underlying the loan is in the process of being revalued. The Company’s internal credit risk grades are based on the definitions currently utilized by the banking regulatory agencies. The grades assigned and definitions are as follows, and loans graded excellent, above average, good and watch list (risk ratings 1-5) are treated as “pass” for grading purposes. The “criticized” risk rating (6) and the “classified” risk ratings (7-9) are detailed below: 6 – Special Mention- Loans currently performing but with potential weaknesses including adverse trends in borrower’s operations, credit quality, financial strength, or possible collateral deficiency. 7 – Substandard - Loans that are inadequately protected by current sound worth, paying capacity, and collateral support. Loans on “nonaccrual” status. The loan needs special and corrective attention. 8 – Doubtful - Weaknesses in credit quality and collateral support make full collection improbable, but pending reasonable factors remain sufficient to defer the loss status. 9 – Loss - Continuance as a bankable asset is not warranted. However, this does not preclude future attempts at partial recovery. The following table presents the loan portfolio types summarized by the aggregate pass rating and the classified ratings of special mention and substandard within the Company’s internal risk rating system as of September 30, 2022 (in thousands). As of September 30, 2022, the Company had no loans with the classified rating of doubtful or loss. Pass Special Mention Substandard Total Residential one-to-four family $ 241,324 $ 485 $ 429 $ 242,238 Commercial and multi-family 2,122,215 20,064 22,041 2,164,320 Construction 149,923 - 3,180 153,103 Commercial business (1) 196,583 4,760 4,318 205,661 Home equity (2) 55,803 49 212 56,064 Consumer 2,545 - - 2,545 Total Gross Loans $ 2,768,393 $ 25,358 $ 30,180 $ 2,823,931 _________ (1) Includes business lines of credit. (2) Includes home equity lines of credit. The following table presents the loan portfolio types summarized by the aggregate pass rating and the classified ratings of special mention and substandard within the Company’s internal risk rating system as of December 31, 2021 (in thousands). As of December 31, 2021, the Company had no loans with the classified rating of doubtful or loss. Pass Special Mention Substandard Total Residential one-to-four family $ 223,660 $ 505 $ 369 $ 224,534 Commercial and multi-family 1,647,701 45,087 27,386 1,720,174 Construction 151,057 - 2,847 153,904 Commercial business (1) 178,056 4,767 8,316 191,139 Home equity (2) 50,230 - 239 50,469 Consumer 3,717 - - 3,717 Total Gross Loans $ 2,254,421 $ 50,359 $ 39,157 $ 2,343,937 ________ (1) Includes business lines of credit. (2) Includes home equity lines of credit.

Stockholders' Equity

Stockholders' Equity	9 Months Ended
	Sep. 30, 2022
Stockholders' Equity [Abstract]
Stockholders' Equity	Note 8 – Stockholders’ Equity On September 23, 2022, the company closed a round of private placement of Series I Noncumulative Perpetual Stock, par value $ 0.01 per share (the “Series I Preferred Stock”), resulting in gross proceeds of $ 4,440,000 for 444 shares. On May 1, 2022, the Company redeemed all 940 outstanding shares of it’s Series D 4.5 % Noncumulative Perpetual Preferred Stock, at their face value of $ 10,000 per share, for a total redemption amount of $ 9.4 million. On March 24, 2022, BCB Bancorp, Inc. (the “Company”) closed a round of private placement of Series I Noncumulative Perpetual Stock, par value $ 0.01 per share (the “Series I Preferred Stock”), resulting in gross proceeds of $ 2,620,000 for 260 shares. On February 4, 2022, the Company redeemed all 533 outstanding shares of its Series G 6.0 % Noncumulative Perpetual Preferred Stock, at their face value of $ 10,000 per share, for a total redemption amount of $ 5.3 million. On December 21, 2021, BCB Bancorp, Inc. (the “Company”) closed a round of private placement of Series I Noncumulative Perpetual Stock, par value $ 0.01 per share (the “Series I Preferred Stock”), resulting in gross proceeds of $ 3,200,000 for 320 shares.

Bank Owned Life Insurance

Bank Owned Life Insurance	9 Months Ended
	Sep. 30, 2022
Bank Owned Life Insurance [Abstract]
Bank Owned Life Insurance	Note 9 – Bank Owned Life Insurance The Bank purchased an additional $ 8.5 million of bank owned life insurance (“BOLI”) in January, 2021. BOLI involves life insurance purchased by the Bank on a chosen group of employees, and the Bank is owner and beneficiary of the policies. At September 30, 2022 the Bank had $ 71.1 million in BOLI. BOLI is accounted for using the cash surrender value method and is recorded at its net realizable value.

Goodwill and Other Intangible A

Goodwill and Other Intangible Assets	9 Months Ended
	Sep. 30, 2022
Goodwill and Other Intangible Assets [Abstract]
Goodwill and Other Intangible Assets	Note 10 – Goodwill and Other Intangible Assets The Company’s intangible assets consist of goodwill and core deposit intangibles in connection with the acquisition of IA Bancorp, Inc. as of April 17, 2018. The initial recording of goodwill and other intangible assets requires subjective judgments concerning estimates of the fair value of the acquired assets and assumed liabilities. Goodwill is not amortized but is subject to annual tests for impairment or more often if events or circumstances indicate it may be impaired. The Company’s core deposit intangibles are amortized on an accelerated basis using an estimated life of 10 years and in accordance with U.S. GAAP are evaluated annually for impairment. An impairment loss will be recognized if the carrying amount of the intangible asset is not recoverable and exceeds fair value. The carrying amount of the intangible asset is not considered recoverable if it exceeds the sum of the undiscounted cash flows expected to result from the use of the asset. The Company believes that the fair values of its goodwill and other intangible assets were in excess of their carrying amounts and there was no impairment at September 30, 2022. Amortization expense of the core deposit intangibles was $ 12,000 and $ 37,000 for the three and nine months ended September 30, 2022, respectively, and $ 14,000 and $ 43,000 for the three and nine months ended September 30, 2021. The unamortized balance of the core deposit intangibles and the amount of goodwill at September 30, 2022 was $ 141,000 and $ 5.2 million, respectively. The unamortized balance of the core deposits intangibles and the amount of goodwill at September 30, 2021 was $ 191,000 and $ 5.3 million, respectively.

Fair Value of Financial Instrum

Fair Value of Financial Instruments	9 Months Ended
	Sep. 30, 2022
Fair Value of Financial Instruments [Abstract]
Fair Value of Financial Instruments	Note 11 – Fair Values of Financial Instruments Guidance on fair value measurements establishes a fair value hierarchy that prioritizes the inputs to valuation methods used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets and liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy are as follows: Level 1 : Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities. Level 2 : Quoted prices in markets that are not active, or inputs that are observable either directly or indirectly, for substantially the full term of the asset or liability. Level 3 : Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e. supported with little or no market activity). An asset or liability’s level within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement. Assets that the Company measured at fair value on a recurring basis were as follows (In thousands): (Level 1) (Level 2) Quoted Prices in Significant (Level 3) Active Markets Other Significant for Identical Observable Unobservable Description Total Assets Inputs Inputs As of September 30, 2022: Securities Debt Securities Available for Sale $ 92,751 $ - $ 92,751 $ - Marketable Equities $ 18,408 $ 18,408 $ - $ - Total Securities $ 111,159 $ 18,408 $ 92,751 $ - As of December 31, 2021: Securities Debt Securities Available for Sale $ 85,186 $ - $ 85,186 $ - Marketable Equities $ 25,187 $ 25,187 $ - $ - Total Securities $ 110,373 $ 25,187 $ 85,186 $ - The Company’s policy is to recognize transfers between levels as of the actual date of the event or change in circumstances that caused the transfer. There were no transfers of assets or liabilities into or out of Level 1, Level 2, or Level 3 of the fair value hierarchy during the three months ended September 30, 2022 and 2021. There were no liabilities measured at fair value on a recurring basis at September 30, 2022 or December 31, 2021. Assets that the Company measured at fair value on a nonrecurring basis were as follows. (In thousands): (Level 1) (Level 2) Quoted Prices in Significant (Level 3) Active Markets Other Significant for Identical Observable Unobservable Description Total Assets Inputs Inputs As of September 30, 2022 Impaired Loans $ 4,900 $ - $ - $ 4,900 Other real estate owned $ 75 $ - $ - $ 75 As of December 31, 2021: Impaired Loans $ 14,796 $ - $ - $ 14,796 Other real estate owned $ 75 $ - $ - $ 75 There were no liabilities measured at fair value on a recurring basis at September 30, 2022 or December 31, 2021. Note 11 – Fair Values of Financial Instruments (Continued) The following tables present additional quantitative information as of September 30, 2022 and December 31, 2021 about assets measured at fair value on a nonrecurring basis and for which the Company has utilized adjusted Level 3 inputs to determine fair value. (Dollars in thousands): Quantitative Information about Level 3 Fair Value Measurements Fair Value Valuation Unobservable Estimate Techniques Input Range September 30, 2022: Impaired Loans $ 4,900 Appraisal of collateral (1) Appraisal adjustments (2) 0 %- 10 % Other real estate owned $ 75 Appraisal of collateral (1) Appraisal adjustments (2) 0 %- 10 % Fair Value Valuation Unobservable Estimate Techniques Input Range December 31, 2021: Impaired Loans $ 14,796 Appraisal of collateral (1) Appraisal adjustments (2) 0 %- 10 % Other real estate owned $ 75 Appraisal of collateral (1) Appraisal adjustments (2) 0 %- 10 % (1) Fair value is generally determined through independent appraisals of the underlying collateral, which generally include various level 3 inputs which are not objectively determinable. (2) Appraisals may be adjusted by management for qualitative factors such as economic conditions and estimated liquidation expenses. The range of liquidation expenses and other appraisal adjustments are presented as a percent of the appraisal. The following information should not be interpreted as an estimate of the fair value of the entire Company since a fair value calculation is only provided for a limited portion of the Company’s assets and liabilities. Due to a wide range of valuation techniques and the degree of subjectivity used in making the estimates, comparisons between the Company’s disclosures and those of other companies may not be meaningful. The following methods and assumptions were used to estimate the fair values of the Company’s financial instruments as of September 30, 2022 and December 31, 2021. Cash and Cash Equivalents and Interest-Earning Time Deposits (Carried at Cost) The carrying amounts reported in the consolidated statements of financial condition for cash and short-term instruments approximate fair values. Securities (Carried at Fair Value) The fair value of securities is determined by obtaining quoted market prices on nationally recognized security exchanges (Level 1) or, by matrix pricing (Level 2), which is a mathematical technique used widely in the industry to value debt securities without relying exclusively on quoted market prices for the specific securities but rather by relying on the securities’ relationship to other benchmark quoted prices. Loans Held for Sale (Carried at Cost) The fair value of loans held for sale is determined, when possible, using quoted secondary-market prices. If no such quoted prices exist, the fair value of a loan is determined using quoted prices for a similar loan or loans, adjusted for specific attributes of that loan. Loans held for sale are carried at the lower of cost or fair value. Loans Receivable (Carried at Cost) The fair values of loans, except for certain impaired loans, are estimated using discounted cash flow analyses, using market rates at the date of the Statement of Financial Condition that reflect the credit and interest rate-risk inherent in the loans. Projected future cash flows are calculated based upon contractual maturity or call dates, projected repayments and prepayments of principal. Generally, for variable rate loans that reprice frequently and with no significant change in credit risk, fair values are based on carrying values. Note 11 – Fair Values of Financial Instruments (Continued) Impaired Loans (Generally Carried at Fair Value) Impaired loans are those for which the Company has measured and recorded an impairment generally based on the fair value of the loan’s collateral, less estimated costs to sell. Fair value is generally determined based upon independent third-party appraisals of the properties, or discounted cash flows based upon the expected proceeds. These assets are included as Level 3 fair values, based upon the lowest level of input that is significant to the fair value measurements. The fair value at September 30, 2022 and December 31, 2021 consisted of the loan balances of $ 9.1 million net of a valuation allowance of $ 4.2 million and $ 22.6 million net of a valuation of loan allowance of $ 7.8 million, respectively. Other Real Estate Owned (Generally Carried at Lower of Cost or Fair Value) Real Estate Owned is generally carried at fair value less estimated costs to sell which is determined based upon independent third-party appraisals of the properties or based upon the expected proceeds from a pending sale. These assets are included as Level 3 fair values, based upon the lowest level of input that is significant to the fair value measurements. FHLB of New York Stock (Carried at Cost) The carrying amount of restricted investment in bank stock approximates fair value and considers the limited marketability of such securities. Accrued Interest Receivable and Payable (Carried at Cost) The carrying amount of accrued interest receivable and accrued interest payable approximates its fair value. Deposits (Carried at Cost) The fair values disclosed for demand deposits (e.g., interest and non-interest checking, passbook savings and money market accounts1) are, by definition, equal to the amount payable on demand at the reporting date (i.e., their carrying amounts). Fair values for fixed-rate certificates of deposit are estimated using a discounted cash flow calculation that applies interest rates currently being offered in the market on certificates to a schedule of aggregated expected monthly maturities on time deposits. Debt Including Subordinated Debentures (Carried at Cost) Fair values of debt are estimated using discounted cash flow analysis, based on quoted prices for new long-term debt with similar credit risk characteristics, terms and remaining maturity. Prices obtained from this active market represent a market value that is deemed to represent the transfer price if the liability were assumed by a third party. Off-Balance Sheet Financial Instruments (Disclosed at Cost) Fair values for the Company’s off-balance sheet financial instruments (lending commitments and unused lines of credit) are based on fees currently charged in the market to enter into similar agreements, taking into account, the remaining terms of the agreements and the counterparties’ credit standing. The fair value of these commitments was deemed immaterial and is not presented in the accompanying table. Note 11 – Fair Values of Financial Instruments (Continued) The carrying values and estimated fair values of financial instruments were as follows as of September 30, 2022 and December 31, 2021: As of September 30, 2022 Quoted Prices in Active Significant Significant Carrying Markets for Identical Assets Other Observable Inputs Unobservable Inputs Value Fair Value (Level 1) (Level 2) (Level 3) (In Thousands) Financial assets: Cash and cash equivalents $ 221,024 $ 221,024 $ 221,024 $ - $ - Interest-earning time deposits 735 735 - 735 - Debt securities available for sale 92,751 92,751 - 92,751 - Equity investments 18,408 18,408 18,408 - - Loans held for sale - - - - - Loans receivable, net 2,787,015 2,604,820 - - 2,604,820 FHLB of New York stock, at cost 12,388 12,388 - 12,388 - Accrued interest receivable 11,093 11,093 - 11,093 - Financial liabilities: Deposits 2,712,946 2,400,813 1,749,373 651,440 - Borrowings 212,123 206,426 - 206,426 - Subordinated debentures 37,450 40,502 - 40,502 - Accrued interest payable 837 837 - 837 - As of December 31, 2021 Quoted Prices in Active Significant Significant Carrying Markets for Identical Assets Other Observable Inputs Unobservable Inputs Value Fair Value (Level 1) (Level 2) (Level 3) (In Thousands) Financial assets: Cash and cash equivalents $ 411,629 $ 411,629 $ 411,629 $ - $ - Interest-earning time deposits 735 735 - 735 - Debt securities available for sale 85,186 85,186 - 85,186 - Equity investments 25,187 25,187 25,187 - - Loans held for sale 952 952 - 952 - Loans receivable, net 2,304,942 2,313,204 - - 2,313,204 FHLB of New York stock, at cost 6,084 6,084 - 6,084 - Accrued interest receivable 9,183 9,183 - 9,183 - Financial liabilities: Deposits 2,561,402 2,520,191 1,881,121 639,070 - Debt 71,711 71,214 - 71,214 - Subordinated debentures 37,275 45,020 - 45,020 - Accrued interest payable 1,051 1,051 - 1,051 -

Subordinated Debt

Subordinated Debt	9 Months Ended
	Sep. 30, 2022
Subordinated Debt [Abstract]
Subordinated Debt	Note 12 – Subordinated debt On July 30, 2018, the Company issued $ 33.5 million of fixed-to-floating rate subordinated debentures (the “Notes”) in a private placement. The Notes have a 10 -year term and bear interest at a fixed annual rate of 5.625 % for the first five years of the term (the "Fixed Interest Rate Period"). From and including August 1, 2023, the interest rate will adjust to a floating rate based on the three-month LIBOR plus 2.72 % until redemption or maturity (the "Floating Interest Rate Period"). The Notes are scheduled to mature on August 1, 2028. Subject to limited exceptions, the Company cannot redeem the Notes for the first five years of the term. The Company will pay interest in arrears semi-annually during the Fixed Interest Rate Period and quarterly during the Floating Interest Rate Period during the term of the Notes. The Notes constitute an unsecured and subordinated obligation of the Company and rank junior in right of payment to any senior indebtedness and obligations to general and secured creditors. The Notes qualify as Tier 2 capital for the Company for regulatory purposes, when applicable, and the portion that the Company contributes to the Bank will qualify as Tier 1 capital for the Bank. The additional capital is used for general corporate purposes including organic growth initiatives. Subordinated debt includes associated deferred costs of $ 174,000 and $ 349,000 at September 30, 2022 and December 31, 2021, respectively. The Company also has $ 4,124,000 of mandatory redeemable trust preferred securities. The interest rate on these floating rate junior subordinated debentures adjusts quarterly, equal to the three-month LIBOR plus 2.65 %. As it is anticipated that LIBOR will not be supported in its current form after June 30, 2023, the Company is reviewing the agreements for the above debentures to determine alternative reference rates and does not anticipate there will be a significant financial statement impact.

Lease Obligations

Lease Obligations	9 Months Ended
	Sep. 30, 2022
Lease Obligations [Abstract]
Lease Obligations	Note 13 – Lease Obligations The Company leases 28 of its offices under various operating lease agreements. The leases have remaining terms of one year to 10 years. The leases contain provisions for the payment by the Company of its pro-rata share of real estate taxes, insurance, common area maintenance and other variable expenses. The Company will allocate payments made under such leases between lease and non-lease components. Some leases contain renewal options and options to purchase the assets. The Company has elected not to recognize a lease liability and a right of use asset for leases with a lease term of 12 or fewer months. The following tables present certain information related to the Company’s leases (in thousands): Three Months Ended September 30, 2022 Three Months Ended September 30, 2021 Nine Months Ended September 30, 2022 Nine Months Ended September 30, 2021 Operating lease expense $ 964 $ 917 $ 2,804 $ 2,801 Variable lease expense-operating leases $ 258 $ 236 $ 734 $ 726 At September 30, 2022 At December 31, 2021 Supplemental balance sheet information related to leases: Operating Leases Operating lease right-of-use assets $ 11,785 $ 12,457 Current liabilities $ 3,033 $ 3,296 Operating lease liabilities (noncurrent portion) 9,963 10,529 Imputed Interest ( 894 ) ( 1,073 ) Total operating lease liabilities $ 12,102 $ 12,752 The weighted average remaining lease term for operating leases at September 30, 2022 and December 31, 2021 was 5.63 years and 5.99 years, respectively. The weighted average discount rate for operating leases at September 30, 2022 and December 31, 2021 was 2.39 percent and 2.60 percent, respectively. The following table summarizes the Company’s maturity of lease obligations for operating leases at September 30, 2022 and December 31, 2021 (in thousands): Maturities of lease liabilities: At September 30, 2022 At December 31, 2021 Operating Leases Operating Leases One year or less $ 3,033 $ 3,296 Over one year through three years 4,544 4,455 Over three years through five years 3,082 3,012 Over five years 2,337 3,062 Gross Operating Lease Liabilities $ 12,996 $ 13,825 Imputed Interest ( 894 ) ( 1,073 ) Total Operating Lease Liabilities $ 12,102 $ 12,752

Subsequent Events

Subsequent Events	9 Months Ended
	Sep. 30, 2022
Subsequent Events [Abstract]
Subsequent Events	Note 14 – Subsequent Events On October 11, 2022 , the Board of Directors of the Company declared a cash dividend of $ 0.16 per share to shareholders of record of its common stock on November 1, 2022 with a payment date of November 15, 2022 .

Equity Incentive Plans (Tables)

Equity Incentive Plans (Tables)	9 Months Ended
	Sep. 30, 2022
Equity Incentive Plans [Abstract]
Summary of Status of Restricted Shares	Number of Shares Awarded Weighted Average Grant Date Fair Value Non-vested at January 1, 2022 26,700 $ 12.89 Granted 69,000 17.05 Vested ( 9,150 ) 13.91 Forfeited - - Non-vested at September 30, 2022 86,550 $ 16.19
Summary of Stock Option Activity	Number of Option Shares Range of Exercise Prices Weighted Average Exercise Price Outstanding at January 1, 2022 1,194,425 $ 9.02 - 13.68 $ 11.64 Options granted - - - Options exercised ( 111,950 ) 9.02 - 13.68 11.52 Options forfeited - - - Options expired - - - Outstanding at September 30, 2022 1,082,475 $ 9.02 - 13.68 $ 11.65

Net Income per Common Share (Ta

Net Income per Common Share (Tables)	9 Months Ended
	Sep. 30, 2022
Net Income per Common Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted	For the Three Months Ended September 30, 2022 2021 Income Shares Per Share Income Shares Per Share (Numerator) (Denominator) Amount (Numerator) (Denominator) Amount (In Thousands, except per share data) Basic earnings per share: Income available to common stockholders $ 13,218 16,982 $ 0.78 $ 8,036 17,019 $ 0.47 Effect of dilutive securities: - - - - Stock options - 374 - 203 Diluted earnings per share: Income available to common stockholders $ 13,218 17,356 $ 0.76 $ 8,036 17,222 $ 0.47 For the Nine Months Ended September 30, 2022 2021 Income Shares Per Share Income Shares Per Share (Numerator) (Denominator) Amount (Numerator) (Denominator) Amount (In Thousands, except per share data) Basic earnings per share: Income available to common stockholders $ 32,883 16,986 $ 1.94 $ 22,637 17,085 $ 1.33 Effect of dilutive securities: Stock options - 383 - 157 Diluted earnings per share: Income available to common stockholders $ 32,883 17,369 $ 1.89 $ 22,637 17,242 $ 1.31

Securities (Tables)

Securities (Tables)	9 Months Ended
	Sep. 30, 2022
Securities [Abstract]
Summary of Disaggregated Net Losses on Equity Securities	For the three months ended September 30, For the nine months ended September 30, (In Thousands) 2022 2021 2022 2021 Net (losses) gains recognized during the period on equity securities held at the reporting date $ ( 559 ) $ ( 307 ) $ ( 5,487 ) $ ( 4 ) Net losses recognized during the period on equity securities sold during the period - - ( 59 ) - Realized and unrealized losses on equity investments during the reporting period $ ( 559 ) $ ( 307 ) $ ( 5,546 ) $ ( 4 )
Amortized Cost and Gross Unrealized Gains and Losses on Securities Available for Sale	September 30, 2022 Gross Gross Amortized Unrealized Unrealized Cost Gains Losses Fair Value (In Thousands) Residential Mortgage-backed securities: Less than one year $ - $ - $ - $ - More than one to five years - - - - More than five to ten years 5,754 - 401 5,353 More than ten years 23,708 - 3,620 20,088 Sub-total: 29,462 - 4,021 25,441 Corporate Debt securities: More than five to ten years 66,499 - 3,199 63,300 Sub-total: 66,499 - 3,199 63,300 Municipal obligations: More than ten years 4,025 - 15 4,010 Sub-total: 4,025 - 15 4,010 Total securities $ 99,986 $ - $ 7,235 $ 92,751 December 31, 2021 Gross Gross Amortized Unrealized Unrealized Cost Gains Losses Fair Value (In Thousands) Residential Mortgage-backed securities: Due within one year $ 2,952 $ - $ 114 $ 2,838 More than one to five years 53 - - 53 More than five to ten years 6,317 165 27 6,455 More than ten years 21,555 298 287 21,566 Sub-total: 30,877 463 428 30,912 Corporate Debt securities: More than five to ten years 47,765 2,465 159 50,071 Sub-total: 47,765 2,465 159 50,071 Municipal obligations: Due after ten years 4,104 99 - 4,203 Sub-total: 4,104 99 - 4,203 Total Debt Securities Available $ 82,746 $ 3,027 $ 587 $ 85,186
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value	12 Months or Less More than 12 Months Total Fair Unrealized Fair Unrealized Fair Unrealized Value Losses Value Losses Value Losses (In Thousands) September 30, 2022 Residential mortgage-backed securities $ 19,430 $ 2,441 $ 6,012 $ 1,580 $ 25,442 $ 4,021 Corporate Debt securities 56,521 3,079 5,978 120 62,499 3,199 Municipal bond 4,010 15 4,010 15 $ 79,961 $ 5,535 $ 11,990 $ 1,700 $ 91,951 $ 7,235 December 31, 2021 Residential mortgage-backed securities $ 7,801 $ 159 $ 4,681 $ 269 $ 12,482 $ 428 Corporate Debt Securities 12,324 159 - - 12,324 159 $ 20,125 $ 318 $ 4,681 $ 269 $ 24,806 $ 587

Loans Receivable and Allowanc_2

Loans Receivable and Allowance for Loan Losses (Tables)	9 Months Ended
	Sep. 30, 2022
Loans Receivable and Allowance for Loan Losses [Abstract]
Recorded Investment in Loans Receivable	September 30, 2022 December 31, 2021 (In Thousands) Residential one-to-four family $ 242,238 $ 224,534 Commercial and multi-family 2,164,320 1,720,174 Construction 153,103 153,904 Commercial business (1) 205,661 191,139 Home equity (2) 56,064 50,469 Consumer 2,545 3,717 2,823,931 2,343,937 Less: Deferred loan fees, net ( 3,721 ) ( 1,876 ) Allowance for loan losses ( 33,195 ) ( 37,119 ) Total Loans, net $ 2,787,015 $ 2,304,942 (1) Includes business lines of credit. (2) Includes home equity lines of credit.
Allowance for Loan Losses	The following table sets forth the activity in the Company’s allowance for loan losses for the three and nine months ended September 30, 2022, and the related portion of the allowances for loan losses that is allocated to each loan class, as of September 30, 2022 (in thousands): Residential Commercial & Multi-family Construction Commercial Business (1) Home Equity (2) Consumer Unallocated Total Allowance for loan losses: Beginning Balance, July 1, 2022 $ 2,565 $ 21,157 $ 2,348 $ 7,639 $ 387 $ 17 - $ 34,113 Charge-offs: - - - ( 931 ) - - ( 931 ) Recoveries: 7 - - 2 4 - - 13 (Credit) Provisions: ( 374 ) 390 96 ( 993 ) 75 3 803 - Ending Balance, September 30, 2022 2,198 21,547 2,444 5,717 466 20 803 33,195 Ending Balance attributable to loans: Individually evaluated for impairment 204 - 519 3,509 6 - - 4,238 Collectively evaluated for impairment 1,994 21,547 1,925 2,208 460 20 803 28,957 Ending Balance, September 30, 2022 2,198 21,547 2,444 5,717 466 20 803 33,195 Loans Receivables: Individually evaluated for impairment 4,914 27,090 3,180 4,607 733 - - 40,524 Collectively evaluated for impairment 237,324 2,137,230 149,923 201,054 55,331 2,545 - 2,783,407 Total Gross Loans: $ 242,238 $ 2,164,320 $ 153,103 $ 205,661 $ 56,064 $ 2,545 $ - $ 2,823,931 (1) Includes business lines of credit. (2) Includes home equity lines of credit. Residential Commercial & Multi-family Construction Commercial Business (1) Home Equity (2) Consumer Unallocated Total Allowance for loan losses: Beginning Balance, January 1, 2022 $ 4,094 $ 22,065 $ 2,231 $ 8,000 $ 533 $ 14 $ 182 $ 37,119 Charge-offs: - - - ( 1,703 ) - - - ( 1,703 ) Recoveries: 9 - - 138 9 198 - 354 (Credit) Provisions: ( 1,905 ) ( 518 ) 213 ( 718 ) ( 76 ) ( 192 ) 621 ( 2,575 ) Ending Balance, September 30, 2022 $ 2,198 $ 21,547 $ 2,444 $ 5,717 $ 466 $ 20 $ 803 $ 33,195 _____________________________ (1) Includes business lines of credit. (2) Includes home equity lines of credit. Note 7 - Loans Receivable and Allowance for Loan Losses (Continued) The following table sets forth the activity in the Company’s allowance for loan losses for the three and nine months ended September 30, 2021, and the related portion of the allowances for loan losses that is allocated to each loan class, as of September 30, 2021 (in thousands): Residential Commercial & Multi-family Construction Commercial Business (1) Home Equity (2) Consumer Unallocated Total Allowance for loan losses: Beginning Balance, July 1, 2021 $ 2,911 $ 24,438 $ 2,341 $ 6,852 $ 294 - $ 3 $ 633 $ 37,472 Charge-offs: - - - - - - - - Recovery: - - - 1 3 - - 4 (Credit) Provisions: ( 75 ) 370 ( 307 ) 879 19 20 ( 226 ) 680 Ending Balance September 30, 2021 $ 2,836 $ 24,808 $ 2,034 $ 7,732 $ 316 $ 23 $ 407 $ 38,156 Ending Balance attributable to loans: Individually evaluated for impairment $ 276 $ 1,469 $ 150 $ 5,770 $ 16 $ - $ - $ 7,681 Collectively evaluated for impairment 2,560 23,339 1,884 1,962 300 23 407 30,475 Ending Balance September 30, 2021 $ 2,836 $ 24,808 $ 2,034 $ 7,732 $ 316 $ 23 $ 407 $ 38,156 Loans Receivables: Individually evaluated for impairment $ 5,104 $ 39,356 $ 2,787 $ 10,343 $ 1,273 $ - $ - $ 58,863 Collectively evaluated for impairment 219,226 1,700,620 146,289 151,073 50,836 2,730 - 2,270,774 Total Gross Loans: $ 224,330 $ 1,739,976 $ 149,076 $ 161,416 $ 52,109 $ 2,730 $ - $ 2,329,637 _____________________________ (1) Includes business lines of credit. (2) Includes home equity lines of credit. Residential Commercial & Multi-family Construction Commercial Business (1) Home Equity (2) Consumer Unallocated Total Allowance for loan losses: Beginning Balance, January 1, 2021 $ 3,293 $ 21,772 $ 1,977 $ 6,306 $ 286 $ - $ 5 $ 33,639 Charge-offs: ( 60 ) - - ( 103 ) - ( 198 ) - ( 361 ) Recovery: 27 - - 2 - 9 - 38 (Credit) Provisions: ( 424 ) 3,036 57 1,527 30 212 402 4,840 Ending Balance, September 30, 2021 $ 2,836 $ 24,808 $ 2,034 $ 7,732 $ 316 $ 23 $ 407 $ 38,156 _____________________________ (1) Includes business lines of credit. (2) Includes home equity lines of credit. The following table sets forth the amount recorded in loans receivable at December 31, 2021. The table also details the amount of total loans receivable that are evaluated individually, and collectively, for impairment and the related portion of the allowance for loan losses that is allocated to each loan class (in thousands): Residential Commercial & Multi-family Construction Commercial Business (1) Home Equity (2) Consumer Unallocated Total Allowance for credit losses: Ending Balance attributable to loans: Individually evaluated for impairment $ 265 $ 1,690 $ 210 $ 5,650 $ 13 $ - $ - $ 7,828 Collectively evaluated for impairment 3,829 20,375 2,021 2,350 520 14 182 29,291 Ending Balance, December 31, 2021 $ 4,094 $ 22,065 $ 2,231 $ 8,000 $ 533 $ 14 $ 182 $ 37,119 Loans Receivables: Individually evaluated for impairment $ 4,961 $ 31,745 $ 2,847 $ 8,746 $ 1,083 $ - $ - $ 49,382 Collectively evaluated for impairment 219,573 1,688,429 151,057 182,393 49,386 3,717 - 2,294,555 Total Gross Loans: $ 224,534 $ 1,720,174 $ 153,904 $ 191,139 $ 50,469 $ 3,717 $ - $ 2,343,937 (1) Includes business lines of credit. (2) Includes home equity lines of credit.
Impaired Loans	The following table summarizes the average recorded investment and interest income recognized on impaired loans with no related allowance recorded by portfolio class for the three and nine months ended September 30, 2022 and 2021 (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2022 2022 2021 2021 2022 2022 2021 2021 Average Interest Average Interest Average Interest Average Interest Recorded Income Recorded Income Recorded Income Recorded Income Investment Recognized Investment Recognized Investment Recognized Investment Recognized Loans with no related allowance recorded: Residential one-to-four family $ 2,862 $ 36 $ 3,050 $ 37 $ 2,881 $ 109 $ 2,973 $ 108 Commercial and Multi-family 27,360 315 29,742 271 25,415 901 30,614 830 Construction - - - - - - 929 36 Commercial business (1) 828 3 2,465 65 1,149 73 3,143 104 Home equity (2) 488 7 938 12 474 17 1,048 35 Consumer - - - - - - - - Total Impaired Loans with no allowance recorded: $ 31,538 $ 361 $ 36,195 $ 385 $ 29,919 $ 1,100 $ 38,707 $ 1,113 - - Loans with an allowance recorded: Residential one-to-four family $ 1,989 24 $ 2,110 $ 66 $ 1,964 $ 61 $ 2,302 $ 165 Commercial and Multi-family - 10,942 100 1,125 266 11,204 331 Construction 3,112 - 2,787 3 3,059 22 1,858 6 Commercial business (1) 4,567 - 8,197 24 4,953 65 8,388 141 Home equity (2) 264 - 340 - 276 5 368 2 Consumer - - - - - - - - Total Impaired Loans with an allowance recorded: $ 9,932 $ 24 $ 24,376 $ 193 $ 11,377 $ 419 $ 24,120 $ 645 - - Total Impaired Loans: $ 41,470 $ 385 $ 60,571 $ 578 $ 41,296 $ 1,519 $ 62,827 $ 1,758 __________ (1) Includes business lines of credit. (2) Includes home equity lines of credit. The following table summarizes the recorded investment by portfolio class at September 30, 2022 and December 31, 2021. (in thousands): As of September 30, 2022 As of December 31, 2021 Recorded Unpaid Principal Related Recorded Unpaid Principal Related Investment Balance Allowance Investment Balance Allowance Loans with no related allowance recorded: Residential one-to-four family $ 2,845 $ 3,209 $ - $ 2,950 $ 3,300 $ - Commercial and multi-family 27,090 28,266 - 20,915 22,100 - Construction - - - - - - Commercial business (1) 947 4,910 - 2,114 6,905 - Home equity (2) 504 504 - 779 780 - Total Impaired Loans with no related allowance recorded: $ 31,386 $ 36,889 $ - $ 26,758 $ 33,085 $ - Loans with an allowance recorded: Residential one-to-four family $ 2,069 $ 2,090 $ 204 $ 2,011 $ 2,032 $ 265 Commercial and Multi-family - - - 10,830 14,494 1,690 Construction 3,180 3,180 519 2,847 2,847 210 Commercial business (1) 3,660 8,519 3,509 6,632 17,514 5,650 Home equity (2) 229 229 6 304 304 13 Total Impaired Loans with an allowance recorded: $ 9,138 $ 14,018 $ 4,238 $ 22,624 $ 37,191 $ 7,828 Total Impaired Loans: $ 40,524 $ 50,907 $ 4,238 $ 49,382 $ 70,276 $ 7,828 __________ (1) Includes business lines of credit. (2) Includes home equity lines of credit.
Troubled Debt Restructurings	At September 30, 2022 At December 31, 2021 (In thousands) Recorded investment in TDRs: Accrual status $ 10,503 $ 12,402 Non-accrual status 483 3,570 Total recorded investment in TDRs $ 10,986 $ 15,972
Delinquency Status of Total Loans	The following table sets forth the delinquency status of total loans receivable as of September 30, 2022: Loans Receivable 30-59 Days 60-90 Days Greater Than Total Past Total Loans >90 Days Past Due Past Due 90 Days Due Current Receivable and Accruing (In Thousands) Residential one-to-four family $ 615 $ 187 $ 230 $ 1,032 $ 241,206 $ 242,238 $ 230 Commercial and multi-family 2,245 356 757 3,358 2,160,962 2,164,320 - Construction - - 3,180 3,180 149,923 153,103 - Commercial business (1) 885 47 1,578 2,510 203,151 205,661 - Home equity (2) 199 - - 199 55,865 56,064 - Consumer - - - 2,545 2,545 - Total $ 3,944 $ 590 $ 5,745 $ 10,279 $ 2,813,652 $ 2,823,931 $ 230 _________ (1) Includes business lines of credit. (2) Includes home equity lines of credit. The following table sets forth the delinquency status of total loans receivable at December 31, 2021: Loans Receivable 30-59 Days 60-90 Days Greater Than Total Past Total Loans >90 Days Past Due Past Due 90 Days Due Current Receivable and Accruing (In Thousands) Residential one-to-four family $ 1,063 $ - $ 86 $ 1,149 $ 223,385 $ 224,534 $ - Commercial and multi-family 1,181 - 5,167 6,348 1,713,826 1,720,174 - Construction 2,899 - 2,847 5,746 148,158 153,904 - Commercial business (1) 405 166 6,775 7,346 183,793 191,139 3,124 Home equity (2) 190 - 27 217 50,252 50,469 - Consumer - - - - 3,717 3,717 - Total $ 5,738 $ 166 $ 14,902 $ 20,806 $ 2,323,131 $ 2,343,937 $ 3,124 (1) Includes business lines of credit. (2) Includes home equity lines of credit.
Non-Accruing Loans	As of September 30, 2022 As of December 31, 2021 (In Thousands) (In Thousands) Non-Accruing Loans: Residential one-to-four family $ 263 $ 282 Commercial and multi-family 757 8,601 Construction 3,180 2,847 Commercial business (1) 4,305 3,132 Home equity (2) - 27 Total $ 8,505 $ 14,889 _________ (1) Includes business lines of credit. (2) Includes home equity lines of credit.
Loan Portfolio by Pass Rating	The following table presents the loan portfolio types summarized by the aggregate pass rating and the classified ratings of special mention and substandard within the Company’s internal risk rating system as of September 30, 2022 (in thousands). As of September 30, 2022, the Company had no loans with the classified rating of doubtful or loss. Pass Special Mention Substandard Total Residential one-to-four family $ 241,324 $ 485 $ 429 $ 242,238 Commercial and multi-family 2,122,215 20,064 22,041 2,164,320 Construction 149,923 - 3,180 153,103 Commercial business (1) 196,583 4,760 4,318 205,661 Home equity (2) 55,803 49 212 56,064 Consumer 2,545 - - 2,545 Total Gross Loans $ 2,768,393 $ 25,358 $ 30,180 $ 2,823,931 _________ (1) Includes business lines of credit. (2) Includes home equity lines of credit. The following table presents the loan portfolio types summarized by the aggregate pass rating and the classified ratings of special mention and substandard within the Company’s internal risk rating system as of December 31, 2021 (in thousands). As of December 31, 2021, the Company had no loans with the classified rating of doubtful or loss. Pass Special Mention Substandard Total Residential one-to-four family $ 223,660 $ 505 $ 369 $ 224,534 Commercial and multi-family 1,647,701 45,087 27,386 1,720,174 Construction 151,057 - 2,847 153,904 Commercial business (1) 178,056 4,767 8,316 191,139 Home equity (2) 50,230 - 239 50,469 Consumer 3,717 - - 3,717 Total Gross Loans $ 2,254,421 $ 50,359 $ 39,157 $ 2,343,937 ________ (1) Includes business lines of credit. (2) Includes home equity lines of credit.

Fair Value of Financial Instr_2

Fair Value of Financial Instruments (Tables)	9 Months Ended
	Sep. 30, 2022
Fair Value of Financial Instruments [Abstract]
Fair Value Measurements, Recurring	(Level 1) (Level 2) Quoted Prices in Significant (Level 3) Active Markets Other Significant for Identical Observable Unobservable Description Total Assets Inputs Inputs As of September 30, 2022: Securities Debt Securities Available for Sale $ 92,751 $ - $ 92,751 $ - Marketable Equities $ 18,408 $ 18,408 $ - $ - Total Securities $ 111,159 $ 18,408 $ 92,751 $ - As of December 31, 2021: Securities Debt Securities Available for Sale $ 85,186 $ - $ 85,186 $ - Marketable Equities $ 25,187 $ 25,187 $ - $ - Total Securities $ 110,373 $ 25,187 $ 85,186 $ -
Fair Value Measurements, Nonrecurring	(Level 1) (Level 2) Quoted Prices in Significant (Level 3) Active Markets Other Significant for Identical Observable Unobservable Description Total Assets Inputs Inputs As of September 30, 2022 Impaired Loans $ 4,900 $ - $ - $ 4,900 Other real estate owned $ 75 $ - $ - $ 75 As of December 31, 2021: Impaired Loans $ 14,796 $ - $ - $ 14,796 Other real estate owned $ 75 $ - $ - $ 75
Quantitative Information about Level 3 Fair Value Measurements	Quantitative Information about Level 3 Fair Value Measurements Fair Value Valuation Unobservable Estimate Techniques Input Range September 30, 2022: Impaired Loans $ 4,900 Appraisal of collateral (1) Appraisal adjustments (2) 0 %- 10 % Other real estate owned $ 75 Appraisal of collateral (1) Appraisal adjustments (2) 0 %- 10 % Fair Value Valuation Unobservable Estimate Techniques Input Range December 31, 2021: Impaired Loans $ 14,796 Appraisal of collateral (1) Appraisal adjustments (2) 0 %- 10 % Other real estate owned $ 75 Appraisal of collateral (1) Appraisal adjustments (2) 0 %- 10 % (1) Fair value is generally determined through independent appraisals of the underlying collateral, which generally include various level 3 inputs which are not objectively determinable. (2) Appraisals may be adjusted by management for qualitative factors such as economic conditions and estimated liquidation expenses. The range of liquidation expenses and other appraisal adjustments are presented as a percent of the appraisal.
Carrying Values and Estimated Fair Values of Financial Instruments	As of September 30, 2022 Quoted Prices in Active Significant Significant Carrying Markets for Identical Assets Other Observable Inputs Unobservable Inputs Value Fair Value (Level 1) (Level 2) (Level 3) (In Thousands) Financial assets: Cash and cash equivalents $ 221,024 $ 221,024 $ 221,024 $ - $ - Interest-earning time deposits 735 735 - 735 - Debt securities available for sale 92,751 92,751 - 92,751 - Equity investments 18,408 18,408 18,408 - - Loans held for sale - - - - - Loans receivable, net 2,787,015 2,604,820 - - 2,604,820 FHLB of New York stock, at cost 12,388 12,388 - 12,388 - Accrued interest receivable 11,093 11,093 - 11,093 - Financial liabilities: Deposits 2,712,946 2,400,813 1,749,373 651,440 - Borrowings 212,123 206,426 - 206,426 - Subordinated debentures 37,450 40,502 - 40,502 - Accrued interest payable 837 837 - 837 - As of December 31, 2021 Quoted Prices in Active Significant Significant Carrying Markets for Identical Assets Other Observable Inputs Unobservable Inputs Value Fair Value (Level 1) (Level 2) (Level 3) (In Thousands) Financial assets: Cash and cash equivalents $ 411,629 $ 411,629 $ 411,629 $ - $ - Interest-earning time deposits 735 735 - 735 - Debt securities available for sale 85,186 85,186 - 85,186 - Equity investments 25,187 25,187 25,187 - - Loans held for sale 952 952 - 952 - Loans receivable, net 2,304,942 2,313,204 - - 2,313,204 FHLB of New York stock, at cost 6,084 6,084 - 6,084 - Accrued interest receivable 9,183 9,183 - 9,183 - Financial liabilities: Deposits 2,561,402 2,520,191 1,881,121 639,070 - Debt 71,711 71,214 - 71,214 - Subordinated debentures 37,275 45,020 - 45,020 - Accrued interest payable 1,051 1,051 - 1,051 -

Lease Obligations (Tables)

Lease Obligations (Tables)	9 Months Ended
	Sep. 30, 2022
Lease Obligations [Abstract]
Schedule of Lease Information	Three Months Ended September 30, 2022 Three Months Ended September 30, 2021 Nine Months Ended September 30, 2022 Nine Months Ended September 30, 2021 Operating lease expense $ 964 $ 917 $ 2,804 $ 2,801 Variable lease expense-operating leases $ 258 $ 236 $ 734 $ 726 At September 30, 2022 At December 31, 2021 Supplemental balance sheet information related to leases: Operating Leases Operating lease right-of-use assets $ 11,785 $ 12,457 Current liabilities $ 3,033 $ 3,296 Operating lease liabilities (noncurrent portion) 9,963 10,529 Imputed Interest ( 894 ) ( 1,073 ) Total operating lease liabilities $ 12,102 $ 12,752
Summary of Maturity of Lease Obligations for Operating Leases	Maturities of lease liabilities: At September 30, 2022 At December 31, 2021 Operating Leases Operating Leases One year or less $ 3,033 $ 3,296 Over one year through three years 4,544 4,455 Over three years through five years 3,082 3,012 Over five years 2,337 3,062 Gross Operating Lease Liabilities $ 12,996 $ 13,825 Imputed Interest ( 894 ) ( 1,073 ) Total Operating Lease Liabilities $ 12,102 $ 12,752

Equity Incentive Plans (Narrati

Equity Incentive Plans (Narrative) (Details) - USD ($)					9 Months Ended
	Jan. 12, 2022	Apr. 26, 2021	Feb. 19, 2021	Feb. 10, 2021	Sep. 30, 2022	Sep. 30, 2021
Defined Benefit Plan Disclosure [Line Items]
Options granted
Stock option expense					$ 180,000	$ 175,000
Restricted stock expense					$ 278,000	$ 162,000
Options [Member]
Defined Benefit Plan Disclosure [Line Items]
Shares underlying unexercised options					238,440
Expected future compensation expense, unexercised options					$ 418,000
Expected future compensation expense, weighted average period for recognition					3 years 10 months 28 days
Options Exercisable - Number of Option Shares					844,035
Restricted Stock [Member]
Defined Benefit Plan Disclosure [Line Items]
Expected future expenses relating to non-vested restricted shares					$ 1,100,000
Expected future compensation expense, weighted average period for recognition					1 year 7 months 24 days
2018 Equity Incentive Plan [Member] | Maximum [Member]
Defined Benefit Plan Disclosure [Line Items]
Shares authorized for issuance					1,000,000
2011 Stock Plan [Member] | Maximum [Member]
Defined Benefit Plan Disclosure [Line Items]
Shares authorized for issuance					900,000
Directors [Member]
Defined Benefit Plan Disclosure [Line Items]
Vesting period	4 years
Directors [Member] | Restricted Stock [Member]
Defined Benefit Plan Disclosure [Line Items]
Restricted stock issued	33,000
Directors [Member] | 2018 Equity Incentive Plan [Member] | Options [Member]
Defined Benefit Plan Disclosure [Line Items]
Options granted				66,000
Vesting period				5 years
Directors [Member] | 2018 Equity Incentive Plan [Member] | Restricted Stock [Member]
Defined Benefit Plan Disclosure [Line Items]
Restricted stock issued			300	26,400
Vesting period			2 years	4 years
Certain Officers [Member]
Defined Benefit Plan Disclosure [Line Items]
Options granted		6,800
Vesting period		5 years

Equity Incentive Plans (Summary

Equity Incentive Plans (Summary of Status of Restricted Shares) (Details)	9 Months Ended
	Sep. 30, 2022 $ / shares shares
Equity Incentive Plans [Abstract]
Number of Shares Awarded, Non-vested at beginning of period | shares	26,700
Number of Shares Awarded, Granted | shares	69,000
Number of Shares Awarded, Vested | shares	(9,150)
Number of Shares Awarded, Forfeited | shares
Number of Shares Awarded, Non-vested at end of period | shares	86,550
Weighted Average Grant Date Fair Value, Non-vested at beginning of period | $ / shares	$ 12.89
Weighted Average Grant Date Fair Value, Granted | $ / shares	17.05
Weighted Average Grant Date Fair Value, Vested | $ / shares	13.91
Weighted Average Grant Date Fair Value, Forfeited | $ / shares
Weighted Average Grant Date Fair Value, Non-vested at end of period | $ / shares	$ 16.19

Equity Incentive Plans (Summa_2

Equity Incentive Plans (Summary of Stock Option Activity) (Details) - $ / shares	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Equity Incentive Plans [Abstract]
Outstanding, Beginning Balance - Number of Options			1,194,425
Options Granted - Number of Options
Options Exercised - Number of Options	(111,750)	(31,000)	(111,950)	(31,000)
Options Forfeited - Number of Options
Options Expired - Number of Options
Outstanding, Ending Balance - Number of Options	1,082,475		1,082,475		1,194,425
Outstanding, Range of Exercise Price, Lower Range Limit (per share)			$ 9.02		$ 9.02
Outstanding, Range of Exercise Price, Upper Range Limit (per share)			13.68		13.68
Options Granted, Exercise Price
Options Forfeited - Exercise Price
Options expired - Exercise prices
Options Shares Granted, Range of Exercise Prices, Lower Range Limit			9.02
Options Shares Granted, Range of Exercise Prices, Upper Range Limit			13.68
Outstanding Number of Options, Beginning Balance - Weighted Average Exercise Price			11.64
Number of Options Granted - Weighted Average Exercise Price
Number of Options, Exercised - Weighted Average Exercise Price			11.52
Number of Options Forfeited - Weighted Average Exercise Price
Number of Options Expired - Weighted Average Exercise Price
Outstanding Number of Options, Ending Balance - Weighted Average Exercise Price	$ 11.65		$ 11.65		$ 11.64

Net Income per Common Share (Na

Net Income per Common Share (Narrative) (Details) - shares	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Net Income per Common Share [Abstract]
Anti-dilutive outstanding options	0	0	0	7,015

Net Income Per Common Share (Sc

Net Income Per Common Share (Schedule of Earnings Per Share, Basic and Diluted) (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Net Income per Common Share [Abstract]
Basic earnings per share: Income available to common stockholders	$ 13,218	$ 8,036	$ 32,883	$ 22,637
Diluted earnings per share: Income available to common stockholders	$ 13,218	$ 8,036	$ 32,883	$ 22,637
Basic earnings per share: Income available to common stockholders, Shares	16,982	17,019	16,986	17,085
Effect of dilutive securities: Stock options: Shares	374	203	383	157
Diluted earnings per share: Income available to common stockholders, Shares	17,356	17,222	17,369	17,242
Basic earnings per share: Income available to common stockholders, Per share amount	$ 0.78	$ 0.47	$ 1.94	$ 1.33
Diluted earnings per share: Income available to common stockholders, Per share amount	$ 0.76	$ 0.47	$ 1.89	$ 1.31

Securities (Summary of Disaggre

Securities (Summary of Disaggregated Net Losses on Equity Securities) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Securities [Abstract]
Net (losses) gains recognized during the period on equity securities held at the reporting date	$ (559)	$ (307)	$ (5,487)	$ (4)
Net losses recognized during the period on equity securities sold during the period			(59)
Realized and unrealized losses on equity investments during the reporting period	$ (559)	$ (307)	$ (5,546)	$ (4)

Securities (Amortized Cost and

Securities (Amortized Cost and Gross Unrealized Gains and Losses on Securities Available for Sale) (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Schedule of Available-for-sale Securities [Line Items]
Debt Securities, Amortized Cost	$ 99,986	$ 82,746
Debt securities: Gross Unrealized Gains		3,027
Debt securities: Gross Unrealized Losses	7,235	587
Debt securities: Fair Value	92,751	85,186
Residential Mortgage-backed securities [Member]
Schedule of Available-for-sale Securities [Line Items]
Debt securities, Due within one year, Amortized Cost		2,952
Debt securities, More than one to five years, Amortized Cost		53
Debt securities, More than five to ten years, Amortized Cost	5,754	6,317
Debt securities, More than ten years, Amortized Cost	23,708	21,555
Debt Securities, Amortized Cost	29,462	30,877
Debt securities: More than five to ten years, Gross Unrealized Gains		165
Debt securities, More than ten years, Gross Unrealized Gains		298
Debt securities: Gross Unrealized Gains		463
Debt securities: Due within one year, Gross Unrealized Losses		114
Debt securities: More than five to ten years, Gross Unrealized Losses	401	27
Debt securities: More than ten years, Gross Unrealized Losses	3,620	287
Debt securities: Gross Unrealized Losses	4,021	428
Debt securities: Due within one year, Fair Value		2,838
Debt securities: More than one to five years, Fair Value		53
Debt securities: More than five to ten years, Fair Value	5,353	6,455
Debt securities: More than ten years, Fair Value	20,088	21,566
Debt securities: Fair Value	25,441	30,912
Corporate Debt Securities [Member]
Schedule of Available-for-sale Securities [Line Items]
Debt securities, More than five to ten years, Amortized Cost	66,499	47,765
Debt Securities, Amortized Cost	66,499	47,765
Debt securities: More than five to ten years, Gross Unrealized Gains		2,465
Debt securities: Gross Unrealized Gains		2,465
Debt securities: More than five to ten years, Gross Unrealized Losses	3,199	159
Debt securities: Gross Unrealized Losses	3,199	159
Debt securities: More than five to ten years, Fair Value	63,300	50,071
Debt securities: Fair Value	63,300	50,071
Municipal Obligations [Member]
Schedule of Available-for-sale Securities [Line Items]
Debt securities, More than ten years, Amortized Cost	4,025	4,104
Debt Securities, Amortized Cost	4,025	4,104
Debt securities, More than ten years, Gross Unrealized Gains		99
Debt securities: Gross Unrealized Gains		99
Debt securities: More than ten years, Gross Unrealized Losses	15
Debt securities: Gross Unrealized Losses	15
Debt securities: More than ten years, Fair Value	4,010	4,203
Debt securities: Fair Value	$ 4,010	$ 4,203

Securities (Available-for-Sale

Securities (Available-for-Sale Securities, Continuous Unrealized Loss Position, Fair Value ) (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Schedule of Available-for-sale Securities [Line Items]
Debt Securities, 12 Months or Less - Fair Value	$ 79,961	$ 20,125
Debt Securities, More than 12 Months - Fair Value	11,990	4,681
Debt Securities - Total Fair Value	91,951	24,806
Debt Securities, 12 Months or Less - Unrealized Losses	5,535	318
Debt Securities, More than 12 Months - Unrealized Losses	1,700	269
Debt Securities - Total Unrealized Losses	7,235	587
Municipal Bond [Member]
Schedule of Available-for-sale Securities [Line Items]
Debt Securities, 12 Months or Less - Fair Value	4,010
Debt Securities - Total Fair Value	4,010
Debt Securities, 12 Months or Less - Unrealized Losses	15
Debt Securities - Total Unrealized Losses	15
Residential Mortgage-backed securities [Member]
Schedule of Available-for-sale Securities [Line Items]
Debt Securities, 12 Months or Less - Fair Value	19,430	7,801
Debt Securities, More than 12 Months - Fair Value	6,012	4,681
Debt Securities - Total Fair Value	25,442	12,482
Debt Securities, 12 Months or Less - Unrealized Losses	2,441	159
Debt Securities, More than 12 Months - Unrealized Losses	1,580	269
Debt Securities - Total Unrealized Losses	4,021	428
Corporate Debt Securities [Member]
Schedule of Available-for-sale Securities [Line Items]
Debt Securities, 12 Months or Less - Fair Value	56,521	12,324
Debt Securities, More than 12 Months - Fair Value	5,978
Debt Securities - Total Fair Value	62,499	12,324
Debt Securities, 12 Months or Less - Unrealized Losses	3,079	159
Debt Securities, More than 12 Months - Unrealized Losses	120
Debt Securities - Total Unrealized Losses	$ 3,199	$ 159

Loans Receivable and Allowanc_3

Loans Receivable and Allowance for Loan Losses (Narrative) (Details)	3 Months Ended		9 Months Ended	12 Months Ended
	Sep. 30, 2022 USD ($) loan	Sep. 30, 2021 USD ($) loan	Sep. 30, 2022 USD ($)	Dec. 31, 2021 USD ($)
Accounts, Notes, Loans and Financing Receivable [Line Items]
Non-accrual loans, interest income lost			$ 842,000	$ 1,300,000
Loans acquired with deteriorated credit quality, fair value	$ 0		0	670,000
Troubled debt restructurings, number | loan	1	1
Troubled debt restructurings, amount	$ 180,078	$ 168,102
Troubled debt restructurings, subsequent default, amount	0	$ 232,072
Troubled debt restructuring, subsequent default, number | loan		1
Loans Receivable within 90 Days	8,505,000		8,505,000	14,889,000
Loans receivable, gross	2,823,931,000	$ 2,329,637,000	2,823,931,000	2,343,937,000
Less Than 90 Days Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans Receivable within 90 Days	230,000		230,000	3,800,000
Doubtful [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	0		0	0
Loss [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	$ 0		$ 0	$ 0

Loans Receivable and Allowanc_4

Loans Receivable and Allowance for Loan Losses (Recorded Investment in Loans Receivable) (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021	Sep. 30, 2021
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	$ 2,823,931	$ 2,343,937	$ 2,329,637
Deferred loan fees, net	(3,721)	(1,876)
Allowance for loan losses	(33,195)	(37,119)
Net Loans	2,787,015	2,304,942
Residential [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	242,238	224,534	224,330
Commercial & Multi-Family [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	2,164,320	1,720,174	1,739,976
Construction [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	153,103	153,904	149,076
Commercial Business [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	205,661	191,139	161,416
Home Equity [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	56,064	50,469	52,109
Consumer [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	$ 2,545	$ 3,717	$ 2,730

Loans Receivable and Allowanc_5

Loans Receivable and Allowance for Loan Losses (Allowance for Loan Losses) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Accounts, Notes, Loans and Financing Receivable [Line Items]
Allowance for loan losses: Beginning Balance	$ 34,113	$ 37,472	$ 37,119	$ 33,639
Allowance for loan losses: Charge-offs	(931)		(1,703)	(361)
Allowance for loan losses: Recoveries	13	4	354	38
Allowance for loan losses: (Credit) Provisions		680	(2,575)	4,840
Allowance for loan losses: Ending balance: individually evaluated for impairment	4,238	7,681	4,238	7,681	$ 7,828
Allowance for loan losses: Ending balance: collectively evaluated for impairment	28,957	30,475	28,957	30,475	29,291
Allowance for loan losses: Ending Balance	33,195	38,156	33,195	38,156
Loans receivables: Ending balance: individually evaluated for impairment	40,524	58,863	40,524	58,863	49,382
Loans receivables: Ending balance: collectively evaluated for impairment	2,783,407	2,270,774	2,783,407	2,270,774	2,294,555
Loans receivables: Ending balance	2,823,931	2,329,637	2,823,931	2,329,637	2,343,937
Residential [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Allowance for loan losses: Beginning Balance	2,565	2,911	4,094	3,293
Allowance for loan losses: Charge-offs				(60)
Allowance for loan losses: Recoveries	7		9	27
Allowance for loan losses: (Credit) Provisions	(374)	(75)	(1,905)	(424)
Allowance for loan losses: Ending balance: individually evaluated for impairment	204	276	204	276	265
Allowance for loan losses: Ending balance: collectively evaluated for impairment	1,994	2,560	1,994	2,560	3,829
Allowance for loan losses: Ending Balance	2,198	2,836	2,198	2,836
Loans receivables: Ending balance: individually evaluated for impairment	4,914	5,104	4,914	5,104	4,961
Loans receivables: Ending balance: collectively evaluated for impairment	237,324	219,226	237,324	219,226	219,573
Loans receivables: Ending balance	242,238	224,330	242,238	224,330	224,534
Commercial & Multi-Family [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Allowance for loan losses: Beginning Balance	21,157	24,438	22,065	21,772
Allowance for loan losses: Charge-offs
Allowance for loan losses: Recoveries
Allowance for loan losses: (Credit) Provisions	390	370	(518)	3,036
Allowance for loan losses: Ending balance: individually evaluated for impairment		1,469		1,469	1,690
Allowance for loan losses: Ending balance: collectively evaluated for impairment	21,547	23,339	21,547	23,339	20,375
Allowance for loan losses: Ending Balance	21,547	24,808	21,547	24,808
Loans receivables: Ending balance: individually evaluated for impairment	27,090	39,356	27,090	39,356	31,745
Loans receivables: Ending balance: collectively evaluated for impairment	2,137,230	1,700,620	2,137,230	1,700,620	1,688,429
Loans receivables: Ending balance	2,164,320	1,739,976	2,164,320	1,739,976	1,720,174
Construction [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Allowance for loan losses: Beginning Balance	2,348	2,341	2,231	1,977
Allowance for loan losses: Charge-offs
Allowance for loan losses: Recoveries
Allowance for loan losses: (Credit) Provisions	96	(307)	213	57
Allowance for loan losses: Ending balance: individually evaluated for impairment	519	150	519	150	210
Allowance for loan losses: Ending balance: collectively evaluated for impairment	1,925	1,884	1,925	1,884	2,021
Allowance for loan losses: Ending Balance	2,444	2,034	2,444	2,034
Loans receivables: Ending balance: individually evaluated for impairment	3,180	2,787	3,180	2,787	2,847
Loans receivables: Ending balance: collectively evaluated for impairment	149,923	146,289	149,923	146,289	151,057
Loans receivables: Ending balance	153,103	149,076	153,103	149,076	153,904
Commercial Business [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Allowance for loan losses: Beginning Balance	7,639	6,852	8,000	6,306
Allowance for loan losses: Charge-offs	(931)		(1,703)	(103)
Allowance for loan losses: Recoveries	2	1	138	2
Allowance for loan losses: (Credit) Provisions	(993)	879	(718)	1,527
Allowance for loan losses: Ending balance: individually evaluated for impairment	3,509	5,770	3,509	5,770	5,650
Allowance for loan losses: Ending balance: collectively evaluated for impairment	2,208	1,962	2,208	1,962	2,350
Allowance for loan losses: Ending Balance	5,717	7,732	5,717	7,732
Loans receivables: Ending balance: individually evaluated for impairment	4,607	10,343	4,607	10,343	8,746
Loans receivables: Ending balance: collectively evaluated for impairment	201,054	151,073	201,054	151,073	182,393
Loans receivables: Ending balance	205,661	161,416	205,661	161,416	191,139
Home Equity [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Allowance for loan losses: Beginning Balance	387	294	533	286
Allowance for loan losses: Charge-offs
Allowance for loan losses: Recoveries	4	3	9
Allowance for loan losses: (Credit) Provisions	75	19	(76)	30
Allowance for loan losses: Ending balance: individually evaluated for impairment	6	16	6	16	13
Allowance for loan losses: Ending balance: collectively evaluated for impairment	460	300	460	300	520
Allowance for loan losses: Ending Balance	466	316	466	316
Loans receivables: Ending balance: individually evaluated for impairment	733	1,273	733	1,273	1,083
Loans receivables: Ending balance: collectively evaluated for impairment	55,331	50,836	55,331	50,836	49,386
Loans receivables: Ending balance	56,064	52,109	56,064	52,109	50,469
Consumer [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Allowance for loan losses: Beginning Balance	17	3	14
Allowance for loan losses: Charge-offs				(198)
Allowance for loan losses: Recoveries			198	9
Allowance for loan losses: (Credit) Provisions	3	20	(192)	212
Allowance for loan losses: Ending balance: individually evaluated for impairment
Allowance for loan losses: Ending balance: collectively evaluated for impairment	20	23	20	23	14
Allowance for loan losses: Ending Balance	20	23	20	23
Loans receivables: Ending balance: individually evaluated for impairment
Loans receivables: Ending balance: collectively evaluated for impairment	2,545	2,730	2,545	2,730	3,717
Loans receivables: Ending balance	2,545	2,730	2,545	2,730	3,717
Unallocated [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Allowance for loan losses: Beginning Balance		633	182	5
Allowance for loan losses: Charge-offs
Allowance for loan losses: Recoveries
Allowance for loan losses: (Credit) Provisions	803	(226)	621	402
Allowance for loan losses: Ending balance: individually evaluated for impairment
Allowance for loan losses: Ending balance: collectively evaluated for impairment	803	407	803	407	182
Allowance for loan losses: Ending Balance	803	407	803	407
Loans receivables: Ending balance: individually evaluated for impairment
Loans receivables: Ending balance: collectively evaluated for impairment
Loans receivables: Ending balance

Loans Receivable and Allowanc_6

Loans Receivable and Allowance for Loan Losses (Impaired Loans) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Accounts, Notes, Loans and Financing Receivable [Line Items]
Average Recorded Investment - With no related allowance recorded	$ 31,538	$ 36,195	$ 29,919	$ 38,707
Average Recorded Investment - With an allowance recorded	9,932	24,376	11,377	24,120
Average Recorded Investment - Total	41,470	60,571	41,296	62,827
Interest Income Recognized - With no related allowance recorded	361	385	1,100	1,113
Interest Income Recognized - With an allowance recorded	24	193	419	645
Interest Income Recognized - Total	385	578	1,519	1,758
Recorded Investment - With no related allowance recorded	31,386		31,386		$ 26,758
Recorded Investment - With an allowance recorded	9,138		9,138		22,624
Recorded Investment - Total	40,524		40,524		49,382
Unpaid Principal Balance - With no related allowance recorded	36,889		36,889		33,085
Unpaid Principal Balance - With an allowance recorded	14,018		14,018		37,191
Unpaid Principal Balance - Total	50,907		50,907		70,276
Related Allowance	4,238		4,238		7,828
Residential [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Average Recorded Investment - With no related allowance recorded	2,862	3,050	2,881	2,973
Average Recorded Investment - With an allowance recorded	1,989	2,110	1,964	2,302
Interest Income Recognized - With no related allowance recorded	36	37	109	108
Interest Income Recognized - With an allowance recorded	24	66	61	165
Recorded Investment - With no related allowance recorded	2,845		2,845		2,950
Recorded Investment - With an allowance recorded	2,069		2,069		2,011
Unpaid Principal Balance - With no related allowance recorded	3,209		3,209		3,300
Unpaid Principal Balance - With an allowance recorded	2,090		2,090		2,032
Related Allowance	204		204		265
Commercial & Multi-Family [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Average Recorded Investment - With no related allowance recorded	27,360	29,742	25,415	30,614
Average Recorded Investment - With an allowance recorded		10,942	1,125	11,204
Interest Income Recognized - With no related allowance recorded	315	271	901	830
Interest Income Recognized - With an allowance recorded		100	266	331
Recorded Investment - With no related allowance recorded	27,090		27,090		20,915
Recorded Investment - With an allowance recorded					10,830
Unpaid Principal Balance - With no related allowance recorded	28,266		28,266		22,100
Unpaid Principal Balance - With an allowance recorded					14,494
Related Allowance					1,690
Construction [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Average Recorded Investment - With no related allowance recorded				929
Average Recorded Investment - With an allowance recorded	3,112	2,787	3,059	1,858
Interest Income Recognized - With no related allowance recorded				36
Interest Income Recognized - With an allowance recorded		3	22	6
Recorded Investment - With no related allowance recorded
Recorded Investment - With an allowance recorded	3,180		3,180		2,847
Unpaid Principal Balance - With no related allowance recorded
Unpaid Principal Balance - With an allowance recorded	3,180		3,180		2,847
Related Allowance	519		519		210
Commercial Business [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Average Recorded Investment - With no related allowance recorded	828	2,465	1,149	3,143
Average Recorded Investment - With an allowance recorded	4,567	8,197	4,953	8,388
Interest Income Recognized - With no related allowance recorded	3	65	73	104
Interest Income Recognized - With an allowance recorded		24	65	141
Recorded Investment - With no related allowance recorded	947		947		2,114
Recorded Investment - With an allowance recorded	3,660		3,660		6,632
Unpaid Principal Balance - With no related allowance recorded	4,910		4,910		6,905
Unpaid Principal Balance - With an allowance recorded	8,519		8,519		17,514
Related Allowance	3,509		3,509		5,650
Home Equity [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Average Recorded Investment - With no related allowance recorded	488	938	474	1,048
Average Recorded Investment - With an allowance recorded	264	340	276	368
Interest Income Recognized - With no related allowance recorded	7	12	17	35
Interest Income Recognized - With an allowance recorded			5	2
Recorded Investment - With no related allowance recorded	504		504		779
Recorded Investment - With an allowance recorded	229		229		304
Unpaid Principal Balance - With no related allowance recorded	504		504		780
Unpaid Principal Balance - With an allowance recorded	229		229		304
Related Allowance	6		6		$ 13
Consumer [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Average Recorded Investment - With no related allowance recorded
Average Recorded Investment - With an allowance recorded
Interest Income Recognized - With no related allowance recorded
Interest Income Recognized - With an allowance recorded

Loans Receivable and Allowanc_7

Loans Receivable and Allowance for Loan Losses (Troubled Debt Restructurings) (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Financing Receivable, Modifications [Line Items]
Total recorded investment in TDRs	$ 10,986	$ 15,972
Accrual Status [Member]
Financing Receivable, Modifications [Line Items]
Total recorded investment in TDRs	10,503	12,402
Non-Accrual Status [Member]
Financing Receivable, Modifications [Line Items]
Total recorded investment in TDRs	$ 483	$ 3,570

Loans Receivable and Allowanc_8

Loans Receivable and Allowance for Loan Losses (Delinquency Status of Total Loans) (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	$ 2,823,931	$ 2,343,937
Loans Receivable >90 Days and Accruing	230	3,124
Total Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	10,279	20,806
30 to 59 Days Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	3,944	5,738
60 to 90 Days Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	590	166
Greater than 90 Days Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	5,745	14,902
Current [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	2,813,652	2,323,131
Originated loans [Member] | Residential [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	242,238	224,534
Loans Receivable >90 Days and Accruing	230
Originated loans [Member] | Residential [Member] | Total Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	1,032	1,149
Originated loans [Member] | Residential [Member] | 30 to 59 Days Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	615	1,063
Originated loans [Member] | Residential [Member] | 60 to 90 Days Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	187
Originated loans [Member] | Residential [Member] | Greater than 90 Days Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	230	86
Originated loans [Member] | Residential [Member] | Current [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	241,206	223,385
Originated loans [Member] | Commercial & Multi-Family [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	2,164,320	1,720,174
Loans Receivable >90 Days and Accruing
Originated loans [Member] | Commercial & Multi-Family [Member] | Total Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	3,358	6,348
Originated loans [Member] | Commercial & Multi-Family [Member] | 30 to 59 Days Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	2,245	1,181
Originated loans [Member] | Commercial & Multi-Family [Member] | 60 to 90 Days Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	356
Originated loans [Member] | Commercial & Multi-Family [Member] | Greater than 90 Days Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	757	5,167
Originated loans [Member] | Commercial & Multi-Family [Member] | Current [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	2,160,962	1,713,826
Originated loans [Member] | Construction [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	153,103	153,904
Loans Receivable >90 Days and Accruing
Originated loans [Member] | Construction [Member] | Total Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	3,180	5,746
Originated loans [Member] | Construction [Member] | 30 to 59 Days Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable		2,899
Originated loans [Member] | Construction [Member] | 60 to 90 Days Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable
Originated loans [Member] | Construction [Member] | Greater than 90 Days Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	3,180	2,847
Originated loans [Member] | Construction [Member] | Current [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	149,923	148,158
Originated loans [Member] | Commercial Business [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	205,661	191,139
Loans Receivable >90 Days and Accruing		3,124
Originated loans [Member] | Commercial Business [Member] | Total Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	2,510	7,346
Originated loans [Member] | Commercial Business [Member] | 30 to 59 Days Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	885	405
Originated loans [Member] | Commercial Business [Member] | 60 to 90 Days Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	47	166
Originated loans [Member] | Commercial Business [Member] | Greater than 90 Days Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	1,578	6,775
Originated loans [Member] | Commercial Business [Member] | Current [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	203,151	183,793
Originated loans [Member] | Home Equity [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	56,064	50,469
Loans Receivable >90 Days and Accruing
Originated loans [Member] | Home Equity [Member] | Total Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	199	217
Originated loans [Member] | Home Equity [Member] | 30 to 59 Days Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	199	190
Originated loans [Member] | Home Equity [Member] | 60 to 90 Days Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable
Originated loans [Member] | Home Equity [Member] | Greater than 90 Days Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable		27
Originated loans [Member] | Home Equity [Member] | Current [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	55,865	50,252
Originated loans [Member] | Consumer [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	2,545	3,717
Loans Receivable >90 Days and Accruing
Originated loans [Member] | Consumer [Member] | Total Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable
Originated loans [Member] | Consumer [Member] | 30 to 59 Days Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable
Originated loans [Member] | Consumer [Member] | 60 to 90 Days Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable
Originated loans [Member] | Consumer [Member] | Greater than 90 Days Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable
Originated loans [Member] | Consumer [Member] | Current [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans Receivable	$ 2,545	$ 3,717

Loans Receivable and Allowanc_9

Loans Receivable and Allowance for Loan Losses (Non-Accruing Loans) (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Accounts, Notes, Loans and Financing Receivable [Line Items]
Non-accrual loans	$ 8,505	$ 14,889
Residential [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Non-accrual loans	263	282
Commercial & Multi-Family [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Non-accrual loans	757	8,601
Construction [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Non-accrual loans	3,180	2,847
Commercial Business [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Non-accrual loans	$ 4,305	3,132
Home Equity [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Non-accrual loans		$ 27

Loans Receivable and Allowan_10

Loans Receivable and Allowance for Loan Losses (Loan Portfolio by Pass Rating) (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021	Sep. 30, 2021
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	$ 2,823,931	$ 2,343,937	$ 2,329,637
Pass [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	2,768,393	2,254,421
Special Mention [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	25,358	50,359
Substandard [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	30,180	39,157
Residential [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	242,238	224,534	224,330
Commercial & Multi-Family [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	2,164,320	1,720,174	1,739,976
Construction [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	153,103	153,904	149,076
Commercial Business [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	205,661	191,139	161,416
Home Equity [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	56,064	50,469	52,109
Consumer [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	2,545	3,717	$ 2,730
Originated loans [Member] | Residential [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	242,238	224,534
Originated loans [Member] | Residential [Member] | Pass [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	241,324	223,660
Originated loans [Member] | Residential [Member] | Special Mention [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	485	505
Originated loans [Member] | Residential [Member] | Substandard [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	429	369
Originated loans [Member] | Commercial & Multi-Family [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	2,164,320	1,720,174
Originated loans [Member] | Commercial & Multi-Family [Member] | Pass [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	2,122,215	1,647,701
Originated loans [Member] | Commercial & Multi-Family [Member] | Special Mention [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	20,064	45,087
Originated loans [Member] | Commercial & Multi-Family [Member] | Substandard [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	22,041	27,386
Originated loans [Member] | Construction [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	153,103	153,904
Originated loans [Member] | Construction [Member] | Pass [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	149,923	151,057
Originated loans [Member] | Construction [Member] | Special Mention [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross
Originated loans [Member] | Construction [Member] | Substandard [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	3,180	2,847
Originated loans [Member] | Commercial Business [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	205,661	191,139
Originated loans [Member] | Commercial Business [Member] | Pass [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	196,583	178,056
Originated loans [Member] | Commercial Business [Member] | Special Mention [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	4,760	4,767
Originated loans [Member] | Commercial Business [Member] | Substandard [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	4,318	8,316
Originated loans [Member] | Home Equity [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	56,064	50,469
Originated loans [Member] | Home Equity [Member] | Pass [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	55,803	50,230
Originated loans [Member] | Home Equity [Member] | Special Mention [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	49
Originated loans [Member] | Home Equity [Member] | Substandard [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	212	239
Originated loans [Member] | Consumer [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	2,545	3,717
Originated loans [Member] | Consumer [Member] | Pass [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross	2,545	3,717
Originated loans [Member] | Consumer [Member] | Special Mention [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross
Originated loans [Member] | Consumer [Member] | Substandard [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable, gross

Stockholders' Equity (Narrative

Stockholders' Equity (Narrative) (Details) - USD ($)						3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 23, 2022	May 01, 2022	Mar. 24, 2022	Feb. 04, 2022	Dec. 21, 2021	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Stockholders' Equity Note [Line Items]
Preferred stock, par value per share						$ 0.01		$ 0.01		$ 0.01
Preferred stock redeemed, value								$ 14,730,000
Series D Preferred Stock [Member]
Stockholders' Equity Note [Line Items]
Preferred stock, dividend rate		4.50%					4.50%	4.50%	4.50%	4.50%
Preferred stock redeemed, shares		940
Preferred stock, redemption price		$ 10,000
Preferred stock redeemed, value		$ 9,400,000
Series I Preferred Stock [Member]
Stockholders' Equity Note [Line Items]
Preferred stock, par value per share	$ 0.01		$ 0.01		$ 0.01
Preferred stock, dividend rate						3%		3%		3%
Proceeds from issuance of private placement	$ 4,440,000		$ 2,620,000		$ 3,200,000
Shares issued	444		260		320
Series G Preferred Stock [Member]
Stockholders' Equity Note [Line Items]
Preferred stock, dividend rate				6%			6%	6%	6%	6%
Preferred stock redeemed, shares				533
Preferred stock, redemption price				$ 10,000
Preferred stock redeemed, value				$ 5,300,000

Bank Owned Life Insurance (Narr

Bank Owned Life Insurance (Narrative) (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2022
Bank Owned Life Insurance [Abstract]
Purchases of BOLI	$ 8,500
Bank owned life insurance, amount		$ 71,100

Goodwill and Other Intangible_2

Goodwill and Other Intangible Assets (Narrative) (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Impairment of intangible assets			$ 0
Goodwill	$ 5,200,000	$ 5,300,000	5,200,000	$ 5,300,000
Core Deposit Intangibles [Member]
Amortization expense	12,000	14,000	37,000	43,000
Intangible assets, net	$ 141,000	$ 191,000	$ 141,000	$ 191,000
Intangible asset, useful life			10 years

Fair Value of Financial Instr_3

Fair Value of Financial Instruments (Narrative) (Details) - USD ($)	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Transfers between fair value hierarchy	$ 0	$ 0
Impaired loans	9,138,000		$ 22,624,000
Valuation allowance	4,238,000		7,828,000
Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Liabilities	0		0
(Level 3) Significant Unobservable Inputs [Member] | Impaired Loans [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Impaired loans	9,100,000		22,600,000
Valuation allowance	$ 4,200,000		$ 7,800,000

Fair Value of Financial Instr_4

Fair Value of Financial Instruments (Fair Value Measurements, Recurring) (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt Securities Available for Sale	$ 92,751	$ 85,186
Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt Securities Available for Sale	92,751	85,186
Marketable Equities	18,408	25,187
Total Securities	111,159	110,373
(Level 1) Quoted Prices In Active Markets For Identical Assets [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt Securities Available for Sale
Marketable Equities	18,408	25,187
(Level 1) Quoted Prices In Active Markets For Identical Assets [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt Securities Available for Sale
Marketable Equities	18,408	25,187
Total Securities	18,408	25,187
(Level 2) Significant Other Observable Inputs [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt Securities Available for Sale	92,751	85,186
Marketable Equities
(Level 2) Significant Other Observable Inputs [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt Securities Available for Sale	92,751	85,186
Marketable Equities
Total Securities	92,751	85,186
(Level 3) Significant Unobservable Inputs [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt Securities Available for Sale
Marketable Equities
(Level 3) Significant Unobservable Inputs [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt Securities Available for Sale
Marketable Equities
Total Securities

Fair Value of Financial Instr_5

Fair Value of Financial Instruments (Fair Value Measurements, Nonrecurring) (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Impaired loans	$ 4,900	$ 14,796
Other real estate owned	75	75
(Level 1) Quoted Prices In Active Markets For Identical Assets [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Impaired loans
Other real estate owned
(Level 2) Significant Other Observable Inputs [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Impaired loans
Other real estate owned
(Level 3) Significant Unobservable Inputs [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Impaired loans	4,900	14,796
Other real estate owned	$ 75	$ 75

Fair Value of Financial Instr_6

Fair Value of Financial Instruments (Quantitative Information about Level 3 Fair Value Measurements) (Details) $ in Thousands	Sep. 30, 2022 USD ($) item	Dec. 31, 2021 USD ($) item
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Impaired Loans | $	$ 4,900	$ 14,796
Other Real Estate Owned | $	75	75
(Level 3) Significant Unobservable Inputs [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Impaired Loans | $	4,900	14,796
Other Real Estate Owned | $	$ 75	$ 75
(Level 3) Significant Unobservable Inputs [Member] | Minimum [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Impaired Loans, Range | item	0	0
Other Real Estate Owned, Range | item	0	0
(Level 3) Significant Unobservable Inputs [Member] | Maximum [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Impaired Loans, Range | item	10	10
Other Real Estate Owned, Range | item	10	10

Fair Value of Financial Instr_7

Fair Value of Financial Instruments (Carrying Values and Estimated Fair Values of Financial Instruments) (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities available for sale	$ 92,751	$ 85,186
Carrying Value [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	221,024	411,629
Interest-earning time deposits	735	735
Debt securities available for sale	92,751	85,186
Equity investments	18,408	25,187
Loans held for sale		952
Loans receivable, net	2,787,015	2,304,942
FHLB of New York stock, at cost	12,388	6,084
Accrued interest receivable	11,093	9,183
Deposits	2,712,946	2,561,402
Debt	212,123	71,711
Subordinated debentures	37,450	37,275
Accrued interest payable	837	1,051
Fair Value [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	221,024	411,629
Interest-earning time deposits	735	735
Debt securities available for sale	92,751	85,186
Equity investments	18,408	25,187
Loans held for sale		952
Loans receivable, net	2,604,820	2,313,204
FHLB of New York stock, at cost	12,388	6,084
Accrued interest receivable	11,093	9,183
Deposits	2,400,813	2,520,191
Debt	206,426	71,214
Subordinated debentures	40,502	45,020
Accrued interest payable	837	1,051
(Level 1) Quoted Prices In Active Markets For Identical Assets [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	221,024	411,629
Interest-earning time deposits
Debt securities available for sale
Equity investments	18,408	25,187
Loans held for sale
Loans receivable, net
FHLB of New York stock, at cost
Accrued interest receivable
Deposits	1,749,373	1,881,121
Debt
Subordinated debentures
Accrued interest payable
(Level 2) Significant Other Observable Inputs [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents
Interest-earning time deposits	735	735
Debt securities available for sale	92,751	85,186
Equity investments
Loans held for sale		952
Loans receivable, net
FHLB of New York stock, at cost	12,388	6,084
Accrued interest receivable	11,093	9,183
Deposits	651,440	639,070
Debt	206,426	71,214
Subordinated debentures	40,502	45,020
Accrued interest payable	837	1,051
(Level 3) Significant Unobservable Inputs [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents
Interest-earning time deposits
Debt securities available for sale
Equity investments
Loans held for sale
Loans receivable, net	2,604,820	2,313,204
FHLB of New York stock, at cost
Accrued interest receivable
Deposits
Debt
Subordinated debentures
Accrued interest payable

Subordinated Debt (Narrative) (

Subordinated Debt (Narrative) (Details) - USD ($)	9 Months Ended
	Sep. 30, 2022	Dec. 31, 2021	Jul. 30, 2018
Trust Preferred Securities Subject To Mandatory Redemption [Member]
Subordinated Borrowing [Line Items]
Variable interest rate spread	2.65%
Trust preferred securities	$ 4,124,000
Fixed To Floating Rate Subordinated Debentures [Member]
Subordinated Borrowing [Line Items]
Face amount			$ 33,500,000
Notes term	10 years
Redemption restriction period	5 years
Deferred finance costs	$ 174,000	$ 349,000
Fixed To Floating Rate Subordinated Debentures [Member] | First Five Years [Member]
Subordinated Borrowing [Line Items]
Interest rate	5.625%
Fixed To Floating Rate Subordinated Debentures [Member] | After Five Years [Member]
Subordinated Borrowing [Line Items]
Variable interest rate spread	2.72%

Lease Obligations (Narrative) (

Lease Obligations (Narrative) (Details) - item	9 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Lessee, Lease, Description [Line Items]
Number of operating leases	28
Weighted average remaining lease term, operating leases	5 years 7 months 17 days	5 years 11 months 26 days
Weighted average discount rate, operating leases	2.39%	2.60%
Minimum [Member]
Lessee, Lease, Description [Line Items]
Remaining lease terms	1 year
Maximum [Member]
Lessee, Lease, Description [Line Items]
Remaining lease terms	10 years

Lease Obligations (Schedule of

Lease Obligations (Schedule of Lease Information) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Commitments and Contingencies [Abstract]
Operating lease expense	$ 964	$ 917	$ 2,804	$ 2,801
Variable lease expense-operating leases	258	$ 236	734	$ 726
Operating lease right-of-use assets	11,785		11,785		$ 12,457
Current liabilities	3,033		3,033		3,296
Operating lease liabilities (noncurrent portion)	9,963		9,963		10,529
Imputed Interest	(894)		(894)		(1,073)
Total operating lease liabilities	$ 12,102		$ 12,102		$ 12,752

Lease Obligations (Summary of M

Lease Obligations (Summary of Maturity of Lease Obligations for Operating Leases) (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Commitments and Contingencies [Abstract]
One year or less	$ 3,033	$ 3,296
Over one year through three years	4,544	4,455
Over three years through five years	3,082	3,012
Over five years	2,337	3,062
Gross Operating Lease Liabilities	12,996	13,825
Imputed Interest	(894)	(1,073)
Total Operating Lease Liabilities	$ 12,102	$ 12,752

Subsequent Events (Narrative) (

Subsequent Events (Narrative) (Details) - Subsequent Event [Member]	Oct. 11, 2022 $ / shares
Subsequent Event [Line Items]
Date declared	Oct. 11, 2022
Dividends per common share	$ 0.16
Date of record	Nov. 01, 2022
Date paid	Nov. 15, 2022